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1.1 THE URINARY TRACT
The urinary tract manages the transportation and storage of urine and consist of the 
upper urinary tract and the lower urinary tract (LUT). The upper urinary tract includes 
the kidneys and the ureters. The LUT consists of the urinary bladder, the urethra, the 
external and internal urinary sphincters and the pelvic floor muscles; its anatomy differs 
between men and women. Although the ability to void at a socially appropriate place 
and time does not seem like a complex task for human being, it requires the proper 
functionality of many different complex pathways within the body. Disorders of the LUT 
(functional bladder disorders) create symptoms of the LUT. This thesis aims to improve 
our knowledge on diagnostics and treatment of such disorders and symptoms in the 
context of the bladder-brain connections. 
The micturition-cycle is divided into the storage phase and the voiding phase. Dur-
ing the storage phase the detrusor muscle in the bladder wall is relaxed, creating a 
low-pressure bladder without feeling the urge to void. If the amount of urine exceeds 
a certain threshold, an urge to void is felt. The voiding phase may start if we are in an 
appropriate place to void. During the voiding phase the external urethral sphincter 
relaxes, the detrusor muscle contracts, and the bladder empties. When voiding stops, 
the storage phase starts again. 
1.2 INNERVATION OF THE LUT
The ascending and descending innervation of the LUT is warranted by three nerves (fig 
1). Visceral information from the bladder, bladder neck and urethra, is sent to the pons 
and higher brain areas via both the hypogastric nerve (sympathetic) and the pelvic nerve 
(parasympathetic). These nerves are furthermore responsible for the descending auto-
nomic innervation of the bladder. The somatosensory control and the motor control of 
the external urethral sphincter and genitalia are regulated through the pudendal nerve.1 
The areas in the brain and brainstem involved in somatic and autonomic control of the 
LUT differ as to the specific task of the LUT. The precise working mechanism of these 
structures in the control of the LUT has not yet been completely clarified. The knowledge 
in this field is increasing rapidly, however, partly due to the evolution of dynamic brain 
imaging. Dynamic brain imaging captures the location of activation or deactivation in 
the brain over time during a specific task. The central innervation of the LUT in healthy 
subjects has been investigated using dynamic brain imaging but literature is still scarce. 
Furthermore, these techniques are prone to artefacts, and interpretation of the results 
is complicated. When focusing on LUT control, some brain areas are specifically studied. 
The cortex of the brain includes the primary motor cortex and the primary sensory 
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cortex, each representing a map of the whole body, known as the homunculus.2, 3 Other 
brain areas or systems thought to be involved in LUT control are the prefrontal cortex, 
the basal ganglia, the limbic system, the thalamus, the cerebellum, and the pons.2, 4
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Fig. 1. The innervation of the LUT
1.3 FUNCTIONAL UROLOGY - DISORDERS OF THE LUT
LUT symptoms (LUTS) are divided into storage symptoms and voiding symptoms. 
The pathophysiology of LUT disorders is still unknown, but research suggests that it 
is multifactorial, with the pelvic fl oor muscles and the central innervation playing an 
important role.5, 6 The prevalence of LUTS worldwide ranges from 45% to 64%, which 
implies that about one in two people will experience at least one LUTS in their lives. 
Although the mortality of LUT disorders is very low, the negative impact on the quality 
of life (QoL) appears to be huge. Given the increase of symptoms with increasing age, 
and the steady increase in life expectancy, LUTS are a major healthcare problem with an 
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increasing significant economic and social burden.7-10 The economic burden in the USA 
was estimated at > $ 9 milliard a year and ranges between countries in Europe from € 333 
million to € 1.2 milliard per year.11, 12 Social embarrassment and shame prevents patients 
with urinary incontinence (UI) and other LUTS, from seeking help and treatment. Conse-
quently, these symptoms are underexposed and the currently estimated prevalence is 
most likely underestimated.13, 14 
Storage symptoms can present in the form of UI, increased daytime frequency, urgency, 
and nocturia. Urinary incontinence is sub classified into urgency UI , stress UI and mixed 
UI. Urgency UI is involuntary urine leakage accompanied by or immediately preceded 
by urgency. Stress UI is involuntary urine leakage on effort or exertion, or on sneezing 
or coughing. Mixed UI is both urgency UI and stress UI together.15 Voiding symptoms can 
present in the form of hesitancy, slow stream, intermittency, the feeling of incomplete 
emptying and post-micturition dribble.15 
Within functional urology, various syndromes have been described, e.g. overactive 
bladder (OAB), underactive bladder (UAB) and the bladder pain syndrome (BPS). The 
latter is included in the LUT domain of chronic pelvic pain.16 OAB and UAB can present 
concomitantly.
OAB has the highest prevalence of more than 10% worldwide,7 and is characterized 
by storage symptoms: urinary urgency, with or without urgency UI, usually with urinary 
frequency and nocturia, if there is no proven infection or other obvious pathology.17 
UAB is defined as having voiding symptoms: slow urinary stream, hesitancy and strain-
ing to void, with or without a feeling of incomplete bladder emptying sometimes with 
storage symptoms.18 
The BPS is persistent or recurrent chronic pelvic pain, pressure or discomfort perceived 
to be related to the urinary bladder, accompanied by at least one other urinary symptom 
such as an urgent need to void or urinary frequency.19 
As described above, an intact innervation of the LUT is essential for a proper function 
of the LUT. Within functional urology it is important to distinguish non-neuro-urological 
patients from neuro-urological patients. In neuro-urological patients, the innervation is 
disturbed due to a known neurological disorder, for instance spina bifida (congenital) 
or multiple sclerosis (acquired). Different disorders of the LUT can occur in this patient 
group, such as low bladder compliance or dysfunction of the pelvic floor muscles which 
create various symptoms, like UI, the inability to empty the bladder properly or recurrent 
urinary tract infections. Proper treatment and follow-up are very important to preserve 
kidney function in neuro-urological patients.1, 20
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1.4 DIAGNOSTIC TOOLS IN FUNCTIONAL UROLOGY 
Two different types of diagnostic measurements are often used within functional urol-
ogy. Traditional measurements assess an objective outcome, such as number of voids 
per day, voided volume, pad weight or post-void residual. Patient reported outcome 
measurements (PROMS) are subjective outcomes and indicate a patient’s perception, 
usually obtained through a questionnaire. 
A simple but important traditional diagnostic tool within functional urology is the 
bladder diary or voiding frequency chart. It gives information on the frequency of 
voiding per day and night, and on the average bladder capacity and fluid intake. In the 
outpatient clinic, a uroflowmetry can be performed after which the post void residual 
can be measured. The uroflowmetry measures the strength of the stream, which can 
provide information of the urethra and the tension of the pelvic floor muscles. A more 
invasive investigation is a urodynamic study, in which, using pressure sensors, the com-
pliance and strength of the detrusor muscle can be measured. Detrusor overactivity and 
underactivity, which can occur in patients with OAB or UAB respectively, can be detected 
using a urodynamic study.18, 19 Because neuro-urology patients might be at risk for high 
pressure bladders, urodynamic studies in these patients are important investigations in 
the follow-up.1 
The field of functional urology often uses PROMS, because the differences between 
objective and subjective outcomes are evident in this field. For instance, an individual 
might have a negatively affected quality of life (QoL) due to one incontinence episode 
per day, while the influence of this amount of UI would hardly affect another person’s 
QoL. With the use of PROMS, we can make these perceptions measurable and compa-
rable between patients or within patients over time. Since the evolution of PROMS, many 
questionnaires have been developed measuring different aspect of different diseases. 
It is important that PROMS are phrased in line with the patient’s language and that 
questionnaires are validated in this language. Validation of a questionnaire ensures that 
the questionnaire actually measures what it is supposed to measure. In the Netherlands, 
some PROMS on diseases in the field of functional urology have been translated and 
validated in Dutch.21-29 
As the pathophysiology of diseases in functional urology is still not completely 
known, tools to confirm or reject suspicion of a certain disease of a LUT disorder are 
still lacking. Dynamic brain imaging has been postulated as a possible future diagnostic 
tool in clinical practice. Some important issues need to be addressed, however, before 
this technique can be implemented in clinical practice. For example, how is the central 
innervation of the LUT organized and does the central innervation of the LUT differ 
between patients with LUT disorders and healthy subjects? 
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1.5 DYNAMIC BRIAN IMAGING
The brain represents about 2% of the adult total body weight but consumes an esti-
mated 20% of the oxygen entering the body. To conserve energy, the brain regulates its 
blood flow such that active neurons with increased metabolism receive more blood than 
relatively inactive neurons. Dynamic brain imaging is predicated on this principle and 
therefore an indirect measurement of neuronal activity. In positron emission tomogra-
phy (PET) the increased decay of unstable positron-emitting isotopes in areas with an 
increased metabolism is used to study changes in regional cerebral blood flow.2, 30, 31 This 
technique is minimally invasive except for the injection of isotopes in the bloodstream. In 
functional magnetic resonance imaging (fMRI), the blood oxygenation level-dependent 
(BOLD) signal is used, which is a signal intrinsic to the brain, without the radioactivity 
used in PET. Hemoglobin in blood slightly distorts the magnetic resonance properties 
of hydrogen nuclei in its vicinity. Therefore, the change from oxygenated blood (with 
hemoglobin), to deoxygenated blood (without hemoglobin) is detectable using fMRI.2, 31 
Its non-invasive character makes repeated observations possible, which constitutes a 
major advantage over PET.31 The strength of the magnet in the MRI scanner corresponds 
with the resolution of the acquired data and is expressed as Tesla. The first 7-Tesla MRI 
scanners have been installed in the Netherlands, allowing to acquire high resolution im-
ages and thus a more accurate understanding of the organization in the human brain.32 
Most researchers using neuroimaging perform group analyses which reveal a group’s 
average brain response. These results cannot be translated to individuals, however, as 
we do not know the responses and inter-individual differences in individuals. Clinical 
application of this technique to detect abnormalities in activity patterns in individuals 
with specific symptoms is therefore not yet achieved. Defining the involved brain areas 
and activity patterns of the LUT in healthy individuals is a necessary step towards using 
this technique in clinical practice. 
1.6 THERAPY
Different treatments are available in the field of functional urology, ranging from con-
servative/non-invasive to pharmacological and invasive therapies. As most of the LUT 
diseases are non-lethal, the decision to undergo an invasive treatment should always 
be a shared decision between the patient and urologist in which the risks and benefits 
have to be considered carefully. Usually a step-wise approach is executed starting with 
conservative therapies.20, 33, 34 
Conservative therapies include life style interventions (e.g., weight loss, fluid intake or 
physical exercise) and pelvic floor muscle training. Although effectiveness of these non-
16 Chapter 1
invasive therapies has been proven, patients’ therapy adherence decreases on the long 
term and causes the effect of these therapies to fade.35, 36 Evidence suggests that pelvic 
floor muscle training is effective not only in patients with stress UI, but also in patients 
with urgency UI, mixed UI, pelvic organ prolapse or bowel dysfunction.36 
Many different Pharmacological therapies are available in functional urology. Anti-
muscarinics have been the cornerstone in pharmacotherapy of OAB. Although various 
antimuscarinics differ in pharmacological and pharmacokinetic profiles, the use of the 
majority of these agents is limited because of the suboptimal efficacy or bothersome 
side effects in particular dry-mouth and constipation.37, 38 In 2013, the first beta3 agonist 
became clinically available: mirabegron.33 As the working mechanism is different from 
that of antimuscarinics, beta3 agonists have a different profile of side effects and might 
therefore be beneficial for some patients. The reported dry rates for tolterodine (anti-
muscarinic) and mirabergron were both around 45%, and therapy adherence was also 
comparable between both drugs.39 For the treatment of LUTS attributable to benign 
prostatic hyperplasia, alpha-blockers still have the most established role, despite new 
available drug combinations.40 Pharmacological therapies for other diseases in the 
field of functional urology, such as UAB and BPS, do not yet have a place within clinical 
practice. Some large trials are currently investigating pharmacological therapies for UAB 
and BPS. 
Intermittent self-catheterization is a therapy for patients who are unable to void, or 
have a significant post void residual. The therapy can decrease the risk of renal failure 
and the amount of urinary tract infections in patients with UAB and is often indicated 
in neuro-urological patients, to decrease the bladder pressure and to preserve kidney 
function.18, 20 
Invasive therapies range from minimally invasive treatments to invasive surgery like 
the construction of a urinary diversion. 
Different minimally-invasive surgical options exist for stress UI, with good results for 
both women and men.41, 42 For the treatment of refractory urgency UI, either botulinum 
toxin A injections or sacral neuromodulation are indicated as minimally-invasive thera-
pies. 
Injections with botulinum toxin A is an often-used therapy in patients with neuro-
urological disorders. Botulinum toxin A is described to achieve a long-lasting but 
reversible chemical denervation of the bladder. Possible disadvantages are the need of 
intermittent catheterization, and the occurrence of urinary tract infections.43 
Sacral neuromodulation is another option in patients with refractory urgency UI. This 
implies the placement of an electrode in the sacral foramen alongside a sacral nerve, 
usually S3. Chronic electrical stimulation of the afferent somatic sacral nerve fibers 
inhibits the detrusor muscle.44 The long-term success rates in responders are reported 
to be 67%.45 An accurate screening test is necessary to distinguish responders from 
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non-responders. Patients who have an improvement of at least >50% of symptoms in 
the test-phase are considered as responders and are candidates for the definitive sacral 
neuromodulation system. The test phase is currently the only way to select patients for 
this treatment option; predictive patient characteristics or predictive measurements 
like urodynamic parameters have not yet been defined.46, 47 Sacral neuromodulation for 
neuro-urological patients is thus far not reimbursed, as there is a lack of evidence and it 
is unclear which patients are most suitable.48, 49 
Both in non-neuro-urological patients as in neuro-urological patients with UAB or an 
inability to void, indwelling catheters (suprapubic or urethral) or clean intermittent cath-
eterization can give rise to problems such as urinary tract infections, pain and bleeding. 
The construction of a continent catheterizable urostoma can be considered. As this is 
invasive surgery for a non-lethal disease, the risk and benefits have to be considered. A 
fair comparison is challenging, however, as the literature on the risks of reoperation and 
complications is scarce.50 
1.7 AIMS OF THIS THESIS
In general, the aim of this thesis is to investigate potential diagnostic tools in the field of 
functional urology. This is further specified into two sub aims: 
1) To define the brain areas involved in LUT control in healthy individuals and to in-
vestigate the clinical applicability of dynamic brain imaging as a diagnostic tool of 
functional bladder disorders in individuals.
2) To evaluate and improve traditional and patient reported outcome measurements in 
the field of functional urology. 
1.8 OUTLINE OF THIS THESIS
Part I. The use of dynamic brain imaging as potential diagnostic tool within 
functional urology.
The first part of this thesis is dedicated to the innervation of the LUT and the applicabil-
ity of dynamic brain imaging as a diagnostic tool in individuals. Firstly, to define the 
brain areas involved in motor control of the LUT, all evidence on this topic is summarized 
with a thorough systematic review, including a coordinate-based meta-analysis of all 
included data (chapter 2). In chapter 3 the central motoric innervation of the LUT is 
investigated. Chapter 4 focusses on the sensory innervation of the male genitals. In 
both chapters 3 and 4, the involved brain areas in the whole brain are identified with the 
use of 7 Tesla fMRI on both group level and individual level. 
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Part II. Diagnostics and treatment in functional urology.
As explained above, sacral neuromodulation is an often used therapy for OAB, but we 
can still not predict who will respond to this therapy and who will not. In chapter 5, we 
investigated whether sacral neuromodulation shows an acute effect on the results of 
the urodynamic study. We hypothesized, that urodynamics would enable to discrimi-
nate between responders and non-responders of sacral neuromodulation directly after 
implantation. Besides traditional (objective) measurements, the clinical importance of 
PROMS is increasing, as type and severity of symptoms in patients with OAB can be 
very heterogeneous. One of the PROMS measuring symptom bother and health-related 
quality of life in patients with overactive bladder is the OAB-q SF. In chapter 6, this ques-
tionnaire was translated and validated in Dutch to make it usable in clinical practice in 
the Netherlands. A selection of patients with LUT disorders do not show improvement 
on all available minimally invasive treatments. Given the influence of LUT disorders on 
quality of life, invasive surgery, like the construction of a continent or incontinent uros-
toma, is sometimes inevitable. In chapter 7, the complication rate and reoperation rate 
of continent catheterizable urinary conduits were measured in all patients undergoing 
these surgeries in two large academic hospitals in the last 20 years. 
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ABSTRACT 
Aims: The primary aim of this study is to demonstrate that 7T-fMRI can visualize the 
neural representations of the male pelvic floor in the whole brain of a single subject. 
Methods: 17 healthy male volunteers (age 20-47) were scanned in a 7T-MRI scanner (Phil-
ips Achieva). The scanning protocol consisted of 2 functional runs using a multiband 
echo planar imaging sequence and a T1-weighted scan. The subjects executed 2 motor 
tasks, one involving consecutive pelvic floor muscle contractions (PFMC) and a control 
task with tongue movements. 
Results: In single subjects, results of both tasks were visualized in the cortex, putamen, 
thalamus and the cerebellum. Activation was seen during PFMC in the superomedial 
and inferolateral primary motor cortex (M1), supplementary motor area (SMA), insula, 
mid cingulate gyrus (MCG), putamen, thalamus and in the anterior and posterior lobes 
of the cerebellum. During tongue movement, activation was seen in the inferolateral 
M1, SMA, MCG, putamen, thalamus and anterior and posterior lobes of the cerebellum. 
Tongue activation was found in the proximity of, but not overlapping with, the PFMC 
activation. Connectivity analysis demonstrated differences in neural networks involved 
in PFMC and tongue movement.
Conclusions: This study demonstrated that 7T-fMRI can be used to visualize brain areas 
involved in pelvic floor control in the whole brain of single subjects and defined the 
specific brain areas involved in PFMC. Distinct differences between brain mechanisms 
controlling the pelvic floor and tongue movements were demonstrated using connec-
tivity analysis.
Keywords: Brain mapping, fMRI, 7 tesla, high-field imaging, single subject, primary mo-
tor cortex, pelvic floor. 
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INTRODUCTION
Pelvic floor disorders (PFDs), such as urinary and fecal incontinence as well as pelvic 
organ prolapse, are highly prevalent in both men and women.1 Given the increase of PFD 
symptoms with increasing age and the steady increase in life expectancy, PFD currently 
forms a major healthcare problem with significant economic and social burden.1,2 
The pelvic floor musculature and pelvic organs are innervated by the pudendal and 
pelvic nerves, the activity of which is controlled by various parts of the central nervous 
system. Indeed, over the past decades different studies using a variety of imaging tech-
niques have revealed that many different brain areas are involved in voluntary pelvic 
floor muscle contraction (PFMC).3-8 In healthy volunteers, group analyses showed that 
the primary motor cortex, supplementary motor area (SMA), insula, thalamus and cer-
ebellum can all be activated during PFMC.3,4,8,9 Voluntary control of the pelvic floor must 
be distinguished from involuntary control of the pelvic floor during continence, which is 
controlled by separate central pathways.3
Interestingly, patients suffering from PFD may show different activations of the central 
nervous system during PFMC compared to healthy volunteers.10,11 
FMRI studies using 1.5-or 3-Tesla (T) magnets typically study BOLD (Blood-oxygen-level 
dependent) responses in groups of subjects, which requires additional smoothing to 
compensate for the variability of anatomical structures. Obtaining reliable single-subject 
responses requires higher SNR (Signal-to-Noise Ratio) and BOLD sensitivity. Therefore, 
the use of dynamic brain imaging as a diagnostic tool in individual PFD patients had so 
far only limited value in daily clinical practice. 
Recently, high resolution (voxel size ~1mm3) fMRI at increased field strengths (7T) has 
led to significant improvement in the achievable spatial resolution.12 The increases in 
both SNR and BOLD signal at high-fields12 make single subject imaging possible.13 Fur-
thermore, 7T-fMRI has been used successfully to map digit representations in individu-
als.14 With state-of-the-art 7T-fMRI one can obtain a higher resolution BOLD signals from 
cortical to cerebellar regions simultaneously.15
The primary aim of this study is to demonstrate that 7T-fMRI can visualize the neural 
representations of the male pelvic floor in the whole brain of a single subject. Secondary 
aims are to define the involved brain areas in male pelvic floor control and to compare 
the individual results with our group results in the context of the available literature. 
Furthermore, we aimed to study the differences of functional connectivity of the in-
volved brain areas between both tasks. Movements of tongue muscles, were chosen 
as a control task, because this midline motor task is mainly involved in different, well 
automated voluntary behaviours such as eating and speaking. 
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MATERIALS AND METHODS 
Subjects Approval for this study was given by the Medical Ethics Committee of the 
Erasmus Medical Center Rotterdam (METC 2015-451). All included subjects provided writ-
ten informed consent. Seventeen healthy right-handed male volunteers (mean age 29.6 
SD ±7.8 years) participated in this study. We limited our study to a single sex, since the 
male and female pelvic floor motor control should be anatomically distinguished and 
differences in the central control have not been fully identified.16 Furthermore, our study 
is the first to use 7T-fMRI to study pelvic floor representations in single subjects. Given 
the exploratory design a homogeneous study population was desired. Subject exclusion 
criteria were any known impairment of urogenital or tongue motor innervation; current 
or known neurological, psychiatric or urological disorder(s) and contra-indications for 
MRI. 
Stimuli and functional paradigm All subjects completed the same scanning protocol, 
consisting of two functional runs followed by a T1-weighted anatomical scan. Functional 
runs consisted of two motor tasks (pelvic floor contraction and tongue movement), per-
formed using a block paradigm. Prior to the scanning session, all subjects underwent a 
training session in a mock scanner to ensure correct task execution. During this training 
session motor tasks were performed as described below. For the task ‘pelvic floor muscle 
contraction’, subjects were visually cued to strain their pelvic floor by contracting their 
anal sphincter or perineum. To prevent patients from contracting the gluteal muscles, 
they were instructed to lay still on the MRI bed. The motor task ‘tongue movement’ 
required subjects to perform horizontal tongue movements. During this condition, 
subjects were instructed to keep their mouths closed by passively resting the lips and 
jaws together. Cues were generated in MATLAB using Psychtoolbox (Brainard, 1997) and 
presented on a 32-inch BOLD screen (Cambridge Research Systems, Rochester, UK). The 
active condition was indicated by the text ‘MOVE’ and the rest condition by a fixation 
cross ‘+’. The PFMC task consisted of an active condition of 21.5 seconds, in which the 
subject was instructed to repeatedly contract their pelvic floor followed by 19.5 seconds 
of rest, this cycle was repeated 12 times with an additional rest condition at the start 
of the run, resulting in a total scan time of 500 seconds. The tongue movement task 
consisted of an active condition of 10 seconds followed by a rest condition of 10 seconds. 
This cycle was repeated 24 times with an additional rest condition at the start of the run, 
resulting in a total scan time of 490 seconds. 
Data acquisition All data were acquired on a 7T-MRI scanner (Philips Achieva) using 
a volume transmit coil and a 32-channel receive coil (Nova Medical). Functional data 
was acquired using a multiband echo planar imaging (mb-EPI) sequence with multiband 
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factor 2.17 Whole-brain coverage, with the exception of the most inferior regions of the 
cerebellum and the caudal brainstem, was achieved using the following parameters: 
voxel size: 1.77x1.77x1.75mm3, matrix size: 104x127; FOV=184x223mm; number of slices: 
70,TR/TE=2000/25ms; flip angle=70°; in-plane SENSE factor R=3. Whole-brain anatomical 
data was acquired using the MPRAGE sequence with the following parameters: voxel 
size 0.7x0.7x0.7mm3, matrix size: 352x353, FOV=246mm; number of slices: 249; TR/TE = 
4.4/1.97s, SENSE factors R=1.6 (anterior-posterior) and R=1.5 (right-left); total acquisition 
time 8’35”. To account for the signal loss in infratentorial areas, a dielectric pad of calcium 
titanate (CaTiO3) was placed just below the inion at the back of the subjects’ heads.18 
Data pre-processing All data was reconstructed on an offline workstation using dedi-
cated reconstruction software (Recon Frame, Gyrotools, Zürich, Switzerland). Further 
data processing was done in SPM12 (Wellcome Trust Center for Neuroimaging, London, 
UK). Pre-processing steps included joint image realignment of the functional runs, 
co-registration of the anatomical image to the resulting mean functional image and 
smoothing of functional data with a Gaussian kernel (FWHM 2.5mm). 
Data analysis For the extraction of the peak activation coordinates, anatomical and 
functional data was normalized to the standard brain template of the Montreal Neuro-
logical Institute (MNI152).
First-level statistical analysis was conducted using the General Linear Model (GLM). 
Each functional task was modelled as a boxcar convolved with a canonical hemodynamic 
response function (HRF) and its temporal derivative as basic functions. Realignment pa-
rameters were added as nuisance regressors to account for confounding motion effects. In 
single subjects, activation maps were thresholded at p<0.05 voxel-based family-wise error 
(FWE), if clusters were not found, thresholds were changed to p<0.001 (only in putamen 
and thalamus results). Second-level statistical analysis was conducted using a one-sample 
t-test on individuals’ task responses. Activation maps were thresholded at p<0.001 uncor-
rected for multiple comparisons, if the cluster was not found, the threshold was changed 
to p<0.005 uncorrected. Both single subject and group level cortical activation maps were 
projected on inflated cortical surfaces created in Freesurfer and sampled halfway the grey 
matter (projfrac=0.5). In order to aid the inflation process, all images were first bias cor-
rected (bias FWHM=18, sampling distance=2) and resliced to 1mm isotropic in SPM. 
Functional connectivity analysis Connectivity analysis was performed by calculating 
the correlation between time series from different regions of interest (ROIs) in each 
single subject. ROIs were isolated using individuals’ contrast images. Where necessary, 
for example between primary motor and sensory regions, merged ROIs were manually 
separated in ITK-SNAP. Subsequently, voxel time series were extracted from each ROI 
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per single subject and denoised for signal arising from white matter, grey matter and 
cerebrospinal fluid using linear regression. Furthermore, the task model was added as a 
regressor of no interest. Connectivity was defined as the linear correlation between time 
series of different ROIs, which was computed with the Pearson’s correlation coefficient. 
Single subject correlation matrices were used to compute a mean correlation matrix. 
To assess the overlap of clusters of both tasks in specific brain areas, the dice index was 
calculated using the extracted ROI’s of the single subjects. The dice index was calculated 
for overlap in the M1, SMA, insula and cerebellum ROIs. 
RESULTS
The scanning protocol was completed in all 17 subjects. Data concerning 4 subjects was 
excluded due to motion artefacts (>1mm displacement), yielding a total of 13 subjects 
for in-depth analyses. 
Single subject and group analyses following pelvic floor muscle contraction 
PFMC resulted in significant activation of various different brain regions following analy-
ses of both single subjects and groups (for group results: Table 1). The superomedial 
primary motor cortex (M1) was activated in all subjects. In the group analysis this cluster 
was split into two separate clusters, one more anterior and the other more posterior on 
M1 (Fig. 1). Moreover, on M1, a second, more inferolateral cluster was found bilaterally 
in 11/13 subjects. This inferolateral M1 cluster was also activated bilaterally in the group 
analysis (Fig. 1). In 11 subjects’ active clusters were found in the putamen (8 bilateral/3 
unilateral). Thalamus activation was found in 10 subjects (5 bilateral/5 unilateral). In 
group analysis this resulted in combined activation of the putamen and the thalamus in 
both hemispheres (Fig. 2). Concerning the cerebellum, activation in lobule IV was seen 
bilaterally in 7 subjects and unilaterally in 1 subject (indicated by circles, Fig. 3). More 
posterior, in lobule VI, an active cluster was found bilaterally in 6 subjects and unilateral 
in 5 subjects (Fig. 3). In the posterior lobe of the cerebellum, specifically in lobule VIII, 
active clusters were found during PFMC in 2 subjects bilaterally and in 6 subjects unilat-
erally (data not shown). In the group analysis, cerebellar activation was found in lobule 
IV bilaterally, comparable to the single subject results. The cluster seen in single subjects 
in lobule VI was found unilateral in the left hemisphere of the cerebellum in the group 
analysis. Group analysis did not show activation in lobule VIII. 
Connectivity analyses following pelvic floor muscle contraction
Connectivity analysis was performed in the nine individuals who showed active voxels 
in all ROIs except for the thalamus, the activity of which was not present in a sufficient 
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number of subjects to include it as an ROI in this analysis. Figure 4 shows the results of 
the connectivity analysis. 
Superomedial M1 was highly correlated with the SMA and less correlated with the 
other ROIs. SMA was correlated with superomedial M1, but also other cortical ROIs like 
the MCG, the insula and the inferolateral M1 during PFMC.
Activation during tongue movements
Tongue movements resulted in large active clusters lateral of M1 in all subjects (Fig 1). 
The SMA was found active in all but 3 subjects. Tongue movements showed in 4 subjects’ 
bilateral activation in the putamen and in 1 subject unilateral. In 6 subjects bilateral 
thalamus activation was found, and in 4 subjects unilaterally (Fig 2). 
Cerebellar activation during tongue movement in single subjects was found consis-
tently in lobule VI bilaterally. In 8 subjects’ bilateral activation was also found in lobule VIII 
in the posterior cerebellum and in 2 subjects unilaterally (Fig 3). Group analysis showed 
activity in M1, the SMA, the anterior insula, MCG, putamen, thalamus (presumably in the 
VL/VA nuclei) and the cerebellum (Table 1). The connectivity analysis (n=13) showed that 
M1 correlates with SMA, the insula and the cerebellum (Fig. 5). 
Table 1. Results of group activation whole-brain (MNI) with height threshold T=3.93 p<0.001 uncorrected, 
* T=3.05 p<0.005 uncorrected. 
Region hemisphere
Pelvic Tongue
x y z peak T x y z peak T
SupMed M1 L -12 -26 66 8.77 - - - -
R 12 -24 66 5.79 - - - -
InfLat M1 L -48 -2 52 3.33* -54 -8 40 8.31
R 42 -2 54 3.72* 62 4 28 7.62
SMA L -2 -16 68 6.56 -2 -2 60 4.03
R 2 -6 64 7.62 6 0 64 5.12
MCG L -4 -6 46 5.61 -2 2 38 3.20*
R 8 -4 46 4.83 10 14 40 3.60*
insula L -32 0 12 6.28 -34 -10 14 3.63*
R 46 4 2 6.10 38 -2 12 6.01
putamen L -26 -8 12 12.98 -28 -4 -6 3.85*
R 28 -4 14 9.93 28 2 -6 5.39
thalamus L -12 -16 6 5.11 -14 -20 0 5.86
R 10 -16 8 4.13 12 -16 0 7.28
cerebellum L -16 -48 -14 5.29 -20 -60 -24 8.28
R 10 -46 -10 3.91* 20 -64 -20 7.06
Abbreviations: SupMed: superomedial, M1: Primary motor cortex, InfLat: inferolateral, SMA: Supplementary 
motor area, MCG: Mid cingulate gyrus. 
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Overlap 
The overlap of activation clusters of PFMC and tongue movement in M1, SMA, insula and 
cerebellum was calculated using the ROIs of the same subjects as used for the functional 
connectivity. In the M1 ROIs there was no overlap, the dice index was 0.0 ± 0.0 (mean ± 
standard error (SE)). For SMA (0.12 ± 0.05), insula (0.09 ± 0.04) and especially the cerebel-
lum ROIs (0.04 ± 0.02), the overlap was minor. 
Figure 1. Results of both PFMC and tongue movement tasks presented on the cortex. Left upper corner: 
Inflated MNI brain representing group analysis (p<0.005 uncorrected). The rest: brain-inflations of single 
subjects representing single subject activation (p<0.05 FEW). 
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DISCUSSION
This is the first study demonstrating that 7T-fMRI is a suitable technique to study motor 
behaviour of the pelvic floor in the whole brain of male individuals, showing concomi-
tant cortical, subcortical and cerebellar activation. The superomedial M1, inferolateral 
M1, SMA, MCG, the putamen, the thalamus (VL/VA) and the cerebellum were activated 
during contraction of the pelvic floor. The similarities and differences between the 
results of the individuals and the group results, tell us more about the genesis of group 
results and applicability of group results in individuals. 
Figure 2. Activation in the putamen and thalamus in single subjects (p<0.001 uncorrected) and group 
analysis (p<0.001 uncorrected).
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Cortical representations
Our results showed a strong activation bilaterally in superomedial M1 during contrac-
tion of the pelvic floor consistently in all individuals and in groups analyses. Activation 
of M1 during PFMC was first demonstrated using PET,3 which supplemented the ear-
lier described concept of the homunculus of Penfield and Rasmussen.19 The activation 
found in M1 during PFMC, in the “hip-region” of the homunculus, is in line with other 
conducted neuroimaging studies using group analysis.3,6,7,9,20 In addition, during PFMC, 
in both single subject- and group analysis, a bilateral inferolateral M1 cluster was found, 
directly superior of the tongue clusters. Two studies found activation in the precentral 
gyrus, 3 cm from the midline and suggested that this activation was associated with 
concomitant contraction of the abdominal muscles.3,22 In other publications, a similar 
cluster is visible in some figures, but has not been described in detail.10,21,23 The current 
7T-fMRI results further pinpoint the exact areas in the human motor cortex involved in 
Figure 3. Axial and sagittal coupes of the group analyses of the cerebellum and axial coupes of cerebellar 
activation in single subjects with in circles a more superior coupe of the cerebellum. Single subjects thresh-
old T=5.2, p<0.05 FEW, group threshold T=3.05, p<0.005 uncorrected. 
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PFMC. The group results showed moderate overlap of PFMC and tongue clusters in the 
SMA, but no overlap in M1. The strong somatotopy of M1 has been described exten-
sively, and overlap of clusters in M1 was therefore not expected. Research investigated 
Figure 4. Mean correlation of regions of interest during pelvic floor muscle contraction in n=9.
Figure 5. Mean correlation of regions of interest during tongue movement n=13.
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a possible somatotopy of the SMA and suggested that the cranial to caudal body is 
represented from anterior to posterior respectively in the SMA.24,25 Our results did not 
clearly demonstrate this somatotopy. In these smaller cortical body representations, the 
shorter distances between neighboring body parts results in lager overlap in the BOLD 
results. Note that this does not necessarily mean that the neural circuits for pelvic and 
tongue are shared in SMA, just that they are spatially closer. 
The connectivity analysis showed a strong correlation between the superomedial M1 
and the SMA during PFMC. Previously, it has been suggested that the SMA has a facilita-
tory effect on M1 during voluntary motor tasks.4,26 Di Gangi Herms et al., compared corti-
cal activation of women with stress urinary incontinence before and after pelvic floor 
muscle therapy (PFMT) using 3T-fMRI.23 Prior to the start of the PFMT significant clusters 
were found in the SMA during PFMC; after 12 weeks of daily PFMT this cluster in the SMA 
was not found during PFMC and activation in the M1 was smaller and more focused. Our 
subjects had practiced voluntary PFMC just prior to the 7T-fMRI, and in the connectivity 
analysis we see that the SMA was strongly connected to the M1 and other cortical and 
subcortical areas. The connectivity of the SMA to other brain areas during the tongue 
task was less pronounced than during PFMC and active clusters shown in the SMA dur-
ing tongue movements were smaller (Fig 1). Voluntary tongue movement is necessary 
for speaking and chewing, usually a highly conditioned tasks. This indicates that the 
SMA is especially important in less conditioned movement control, such as PFMC. In this 
context, it is important to realize that cortical and subcortical activations was much more 
consistent among the participants during tongue movement, than during PFMC (Fig 1). 
Putamen
In the present study, PFMC and tongue movement resulted in all single subjects and in 
the group analysis, in activation of the putamen, especially in the caudal putamen (fig 
2). Although specific caudal activation of the putamen during PFMC and tongue move-
ment has not been described previously, activation in the putamen as a whole has been 
observed before during both tasks.6-8,27 The putamen is part of the cortico-basal ganglia 
(BG)-thalamocortical-loop which participates in motor action selection.28 
Thalamus
The last part of the cortico-BG-thalamocortical-loop is the VL/VA nuclei of the thalamus, 
which, in turn, project to the motor cortex.29,30 Our results showed bilateral activation in 
the thalamus during both tasks. In individuals and groups analyses, activation was seen 
possibly in the VL/VA nuclei (fig 2). Activation was not found in all single subjects, but when 
found, it was consistently found on the same location. The current study is the first to show 
these results consistently in individuals. Previous studies on PFMC and tongue movement 
showed activation in thalamus without specification of a thalamic subnucleus.5,6,27 
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The cingulate gyrus 
The mid cingulate gyrus was activated bilaterally during PFMC and tongue movements. 
The location is comparable to previous studies during similar tasks: repetitive PFMC with 
empty bladder.4,5,23 The involvement of this cluster can be explained by the presumed 
role of the MCG in the decision to perform a reward based motor task.31 
The insula
Bilateral anterior insular activity was found during both tasks. Insular activity during 
PFMC and tongue movement is described before, but not particularly in the anterior 
insula.4,20,23,32 The conducted connectivity analysis showed that the insula is connected 
to cortical structures like the SMA but also to the MCG. Evidence suggests that the an-
terior insula is in particular strongly connected to the MCG to regulate attention related 
responses, for instance pelvic floor contractions for retaining continence.33 Additionally, 
the insula shows an increased connectivity to the motor cortex in patients with chronic 
pelvic pain syndrome compared to healthy controls, explained by the insular involve-
ment of visceral sensations.10 In future this might be of great interest to further explore 
the pathophysiology of PDF’s. 
Cerebellum 
The cerebellum contains a double homunculus, one in the anterior lobe and a reversed in 
the posterior lobe.34 We investigated anterior cerebellum activation not only for groups 
but also for single subjects. We found clusters in lobules I-IV of the cerebellum during 
PFMC, and clusters in lobule VI during tongue movement. This ‘up-side-down’ somato-
topic representation of the human body agrees with previously obtained somatotopic 
maps.35 This is the first study to show these results during PFMC in single subjects, which 
are comparable to two other studies on group analysis of cerebellar activations during 
PFMC.3,6 In single subjects, tongue movement created large and consistent clusters in 
the cerebellum compared to PFMC. The ratio of the size of these tongue and PFMC clus-
ters appear comparable to the ratio of the found clusters on the primary motor cortex. 
Tongue movements as control task
Tongue movements were chosen as a control task, since this midline motor task can be 
controlled both voluntarily and involuntarily, like PFMC. PFMC presumably diverges from 
tongue movement, because it may involve more affective-emotional aspects. Moreover, 
tongue movement is a more conditioned motor task, which explains the different con-
nectivity during the two tasks. Existing literature describes active clusters during tongue 
movement in the same brain areas as the active clusters found in the present study with 
comparable coordinates,27,36 also for the cerebellar clusters.35 
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Technical insights
This study analysed both single subject results and group data. In the group results, 
during PFMC, activation in superiomedial M1 is split into two separate clusters with 
less activation compared to the single subject results. The smoothing is indispensable 
when performing group analysis in view of the large inter-subject variability of the brain 
anatomy. Consequently, this might cause disappearance of the less significant findings 
in individuals, like the present clusters in M1. The high folding of the superior end of M1 
further complicates group analysis done in a 3D space. The increased BOLD signal at 
7T-fMRI makes high resolution single subject activation maps available, and allows for 
a more accurate understanding of the central organization in humans.12 Cortical single 
subject results during PFMC have been visualized previously at 3T (see figure 3 in Yani et 
al.21). The direct comparison between 3T and 7T results within individuals is left for future 
work.
Conclusion
We have demonstrated that 7T-fMRI can visualize the neural representations in the whole 
brain involved in voluntary control of the pelvic floor in healthy male subjects. This has 
been done for the first time with whole brain coverage and high-field imaging, creating 
a high spatial resolution and a more accurate understanding of the involved brain areas. 
Our study shows that voluntary PFMC is represented in M1, SMA, MCG, insula, putamen, 
thalamus and the cerebellum. Our connectivity analysis showed distinct differences 
between brain mechanisms controlling PFMC and tongue movement. The present high 
field fMRI study may help to design future 7T studies in individual patients. These stud-
ies should provide new insides on the pathological circuits in order to improve clinical 
practice.
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ABSTRACT
Processing of genital sensations in the central nervous system of humans is still poorly 
understood. Current knowledge is mainly based on neuroimaging studies using elec-
troencephalography (EEG), magneto-encephalography (MEG), and 1.5- or 3- Tesla (T) 
functional magnetic resonance imaging (fMRI), all of which suffer from limited spatial 
resolution and sensitivity, thereby relying on group analyses to reveal significant data. 
Here, we studied the impact of passive, yet non-arousing, tactile stimulation of the 
penile shaft using ultra-high field 7T fMRI. With this approach, penile stimulation evoked 
significant activations in distinct areas of the primary and secondary somatosensory cor-
tices (S1 & S2), premotor cortex, insula, midcingulate gyrus, prefrontal cortex, thalamus 
and cerebellum, both at single subject and group level. Passive tactile stimulation of the 
feet, studied for control, also evoked significant activation in S1, S2, insula, thalamus and 
cerebellum, but predominantly, yet not exclusively, in areas that could be segregated 
from those associated with penile stimulation. Evaluation of the whole-brain activation 
patterns and connectivity analyses indicate that genital sensations following passive 
stimulation are, unlike those following feet stimulation, processed in both sensorimotor 
and affective regions. 
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INTRODUCTION
Human sexual behaviour is characterized by inter- and intrapersonal intimacy. This in-
cludes tactile stimulation of the external genitalia, giving rise to both discriminative and 
affective sensations.1 Despite the evident role of the brain in the perception of touch, it 
remains unclear how tactile input from the external genitalia is centrally processed in 
the healthy individual.
The primary and secondary somatosensory cortices (S1 and S2) are well-recognized as 
the main cortical areas involved in processing the discriminative properties of tactile in-
put. Over the years, studies investigating genital touch in women and men have generally 
focused on S1 due to the counterintuitive location of the genitalia beneath the feet in the 
sensory homunculus.2,3 Some confirm this location, recording cortical evoked responses 
deep in the medial wall of S1 during electrical stimulation of the dorsal nerve of the penis 
(DNP; principal sensory nerve of the penis).4-6 Later functional magnetic resonance imag-
ing studies (fMRI) studies, however, demonstrated significant brain activation dorsolateral 
in the groin region of S1 in response to passive tactile stimulation of the external genita-
lia.7,8 Findings regarding the involvement of S2 in processing tactile penile input show 
more consistency, demonstrating bilateral activation during both electrical6 and tactile 
stimulation.7,8 Other brain regions have also been associated with processing the affec-
tive properties of touch. This includes not only the insula,9 but also the anterior cingulate 
(ACC) and medial prefrontal cortex (mPFC) during tactile stimulation of the forearm.10 
Bilateral activation of the insula has been demonstrated in response to both electrical6 
and tactile penile stimulation.8 Activation of the midcingulate cortex (MCC), but not ACC, 
and mPFC have only been reported following tactile stimulation of the male genitalia.8 
Recently, high field (7 Tesla) fMRI has emerged as a superior neuroimaging technique to 
study human brain function in vivo. Increases in signal-to-noise ratio (SNR) and blood-oxy-
genation-level dependent (BOLD) sensitivity at 7T11,12 have made it possible to acquire data 
with high spatial acuity and demonstrate robust activation in individuals. Recent studies 
showcasing these advantages include mapping the representation of individual digits13 and 
the lower limb14 in S1 at the single subject level. Given the substantial intersubject variability 
of neural representations as well as the need to treat patients as individuals, it has become 
eminently important to study human brain function at the level of individuals.13-15 Moreover, 
signal advantages gained at 7T can not only be observed at a limited field of view such as in 
S1, but also in more extended whole-brain acquisitions16 including the cerebellum.17 
In the present study, we used 7T fMRI to acquire high-resolution neural representations of 
male genital sensation in the whole-brain at both single subject and group level. In order to 
do so, subjects underwent passive tactile stimulation of the genitalia in a way that minimized 
sexual arousal. Passive tactile stimulation of the medial aspect of the feet, performed in an 
equivalent manner as genital stimulation, served as a control task. The feet were deliber-
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ately chosen not only because of their location adjacent to the genitalia in the homunculus, 
but also as a more emotionally neutral stimulus. In addition, the medial aspect of the feet 
is involved in successful electrical therapies for an overactive bladder, like posterior tibial 
nerve stimulation18 or transcutaneous electrical nerve stimulation.19 Therefore, current find-
ings regarding supraspinal activation during tactile stimulation of the feet could provide 
more insight into which regions are targeted and affected by this treatment modality.
We hypothesized that the representation of the external genitalia is located in the 
groin region of S1, lateral to the feet. Furthermore, we hypothesized that passive tactile 
stimulation of the genitalia would lead to activation of brain regions associated with 
processing of both sensorimotor discriminatory (S1 & S2) and affective (insula, MCC and 
mPFC) properties of touch at both single subject and group level. In contrast, passive 
tactile stimulation of the feet would lead to activation of brain regions predominately 
associated with processing discriminatory properties of touch. 
RESULTS
Four subjects were excluded from further analysis due to excessive spike head motion. 
The remaining thirteen subjects were included in first and second level of analyses. 
None of the subjects had an erection whilst undergoing tactile stimulation by the 
experimenter. Tactile stimulation of the penile shaft evoked significant activation su-
peromedial and inferolateral in S1, S2, ventral premotor cortex (vPMC), posterior and 
anterior insula, posterior midcingulate gyrus (pMCG), mPFC, thalamus and cerebellum. 
Responses observed for left and right brushing were similar, and therefore added into a 
single contrast. Tactile stimulation of the feet evoked significant activation superomedial 
and inferolateral in S1, S2, vPMC, posterior insula, thalamus and the cerebellum. 
Representations in S1 
Tactile stimulation of the penile shaft and the feet evoked significant activation (p < 
0.05 family wise error (FWE)) during whole-brain analysis in 11 out of 13 subjects (Fig. 1). 
Bilateral activation was observed superomedial and inferolateral in response to stimula-
tion of the penile shaft. Unilateral activation was observed superomedial in the right 
hemisphere in response to stimulation of the left foot. Bilateral activation was observed 
superomedial in response to stimulation of the right foot. In addition, we also observed 
unilateral activation inferolateral in the left hemisphere. In single subjects, feet activa-
tion clusters extended anteromedial in S1 along the postcentral gyrus. Summation of 
these elongated clusters resulted in fractioning of feet activation clusters at group level 
(Fig. 2). Slight overlap was seen between penile shaft and feet activation clusters. Nev-
ertheless, shaft clusters were consistently found lateral to the feet in the left and right 
hemispheres, both at single subject and group level. 
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Whole-brain results 
To further determine which cortical areas are implicated in processing tactile input from 
the genitalia and the feet outside of S1, we also examined whole-brain responses (Table 
1). Tactile stimulation of the penile shaft elicited bilateral activations in S2, posterior and 
anterior insula, vPMC and the cerebellum. In single subjects, unilateral and bilateral acti-
vations were seen in the pMCG, mPFC and thalamus. At group level, unilateral activation 
in the pMCG was seen in the left hemisphere and bilateral activation was seen in the 
mPFC. We also observed subcortical activation in the medial and posterior regions of 
the thalamus, correlating with reported locations of the medial dorsal (MD) and ven-
tral posterolateral (VPL) nuclei.20,21 Tactile stimulation of the left foot elicited bilateral 
activations in S2, unilateral activation in the posterior insula in the right hemisphere, 
and unilateral activation in the cerebellum in the left hemisphere. Subcortical activation 
was observed posterior in the thalamus in the right hemisphere, presumably the VPL. 
Tactile stimulation of the right foot elicited bilateral activations in S2, posterior insula, 
and unilateral activation in the vPMC in the left hemisphere. Subcortical activation was 
observed posterior in the thalamus (VPL) in both hemispheres. 
Figure 1. Single subject cortical activation patterns. Single subject activation maps (p < 0.05 FWE) from 
all individuals (n=13) displayed on inflated anatomical images showing top-view. Legend in bottom-right 
corner indicating task specific color codes. 
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Representation in the cerebellum 
At lower statistical thresholds, we observed significant activation in the anterior (lobules 
I-IV) and superior posterior lobe (lobule VI) of the cerebellum at both single subject (p < 
0.001 uncorrected for multiple comparisons) and group level (p < 0.005 uncorrected for 
multiple comparisons) (Fig. 3). Shaft and feet representations were found in symmetrical 
locations in both cerebellar hemispheres across 8 out of 13 single subjects (Fig. 3). Tactile 
stimulation of the penile shaft evoked significant bilateral activation in lobule VI in the 
posterior lobe, part of the cerebrocerebellum. In 2 out of 13 individuals (#11, #13) activa-
tion was also seen just posterior to feet clusters in lobule IV. Tactile stimulation of the 
feet evoked significant unilateral activation in lobules IV in the anterior lobe, part of the 
spinocerebellum. In 4 out of 13 individuals (#04, 07, 12, 13) activation was also seen more 
posterior adjacent to the shaft clusters in lobule VI. At group level this was seen for the 
right foot in the contralateral cerebellar hemisphere (Fig. 3). 
Figure 2. Group cortical activation patterns. Group activation maps (p < 0.005 uncorrected for multiple 
comparisons; n=13) displayed on an inflated MNI template showing lateral, medial and top view. A coronal 
section from the MNI template (y=-36) is shown in the bottom-left corner, where the penile shaft is clearly 
located lateral to the feet in S1. Legend in the bottom-right corner indicating task specific color codes. 
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Functional Connectivity 
We also assessed the functional connectivity between timeseries of regions of interest 
(ROIs) for both functional tasks separately (Fig. 4 and Fig. 5). For the penile shaft, time-
series from the superomedial and inferolateral S1, S2, vPMC, posterior insula and the right 
anterior insula showed moderate correlation (range ρ 0.44 - 0.60). The left anterior insula 
showed weak correlation (range ρ 0.36 - 0.49) with the superomedial and inferolateral 
S1, S2, vPMC and posterior insula. Timeseries from the pMCG and cerebellum showed 
weak correlations overall with other ROIs.
For the left foot, timeseries from superomedial S1 in the right hemisphere showed 
a strong correlation with the S2 and posterior insula ROIs on the same side, whereas 
correlation with S2 in the left hemisphere was weaker (Fig. 5A). Timeseries from the 
Table 1. Whole-brain group activation in response to stimulation of the penile shaft and feet versus rest
Region Hemisphere
Penile shaft Foot (left) Foot (right)
x y z t-value x y z t-value x y z t-value
superomedial S1 L -18 -38 68 3.39 -4 -38 72 7.90
R 18 -40 68 3.77 6 -36 70 6.36 18 -40 68 6.07
S2 L -42 -30 -22 4.13 -48 -36 26 4.36 -44 -30 20 5.39
R 40 -30 24 6.19 46 -30 24 5.17 42 -30 22 5.26
inferolateral S1 L -58 -16 34 6.57 -62 -16 36 5.63
R 56 -18 32 4.38
vPMC L -58 6 32 3.42
R 56 6 28 3.66
posterior insula L -36 -16 16 3.13 -36 -18 16 6.74
R 40 -12 14 4.33 34 -14 16 9.04  36 -16 16 5.93
anterior insula L -36 0 12 2.66
R 36 2 14 3.05
pMCG L -12 -24 42 2.12
R
mPFC L -4 52 26 1.89
R 12 60 28 1.81
thalamus L -12 -6 8 2.25 -22 -24 12 5.30
R 18 -22 4 1.68 22 -22 12 4.70 16 -22 12 3.71
cerebellum L -26 -54 -26 2.35 -14 -36 -22 5.09
R 20 -62 -24 2.73         20 -34 -26 4.11
Table 1. Brain regions, MNI coordinates and peak t-values are listed. All activation for the penile shaft is re-
ported using a global null conjunction analysis (p < 0.005 uncorrected for multiple comparisons, t-value > 
1.52). All activation for the left and right feet are reported using a one sample t-test (p < 0.005 uncorrected 
for multiple comparisons, t-value > 3.05). S1: primary somatosensory cortex; S2: secondary somatosensory 
cortex; vPMC: ventral premotor cortex; pMCG: posterior midcingulate gyrus; mPFC: medial prefrontal cor-
tex. 
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cerebellum showed weak correlations overall with other ROIs. A similar, yet inverted, 
correlation pattern was observed for the right foot. Timeseries from superomedial S1 in 
left hemisphere showed high correlation with the S2 and posterior insula on the same 
side, whereas correlation with S2 in the right hemisphere was weaker (Fig. 5B). Timeseries 
from the cerebellum showed weak correlations overall with other ROIs. 
Figure 3. Single subject and group cerebellar activation patterns. Single subject activation maps from all 
individuals (p < 0.001 uncorrected for multiple comparisons) displayed on axial sections containing maxi-
mum number of representations. Group activation maps (p < 0.005 uncorrected for multiple comparisons, 
n=13) displayed on sagittal and axial sections from the MNI template (x and z-coordinates in top-left corner 
indicate position in MNI space). Legend in bottom-right corner indicating task specific color codes. 
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Figure 5. Mean connectivity matrix for left (A) and right (B) foot activation displaying connectivity be-
tween regions of interest. Individual connectivity matrices of 10 single subjects were first generated using 
a Pearson’s correlation coefficient, and used to generate a mean connectivity matrix. Regions included are 
labeled along the axes. 
Figure 4. Mean connectivity matrix for penile shaft activation displaying connectivity between regions of 
interest. Individual connectivity matrices of 9 single subjects were first generated using a Pearson’s cor-
relation coefficient, and subsequently used to generate a mean connectivity matrix. Regions of interest 
included are labeled along axes.
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Distances
The distances between activation foci of penile shaft and feet representations in S1 and 
the cerebellum were measured (Table 2). In S1, vertex distances were measured over the 
cortical surfaces created during the inflation process in Freesurfer. This gives a more true 
representation of distances between cortical representations due to the high degree 
of folding of the postcentral gyrus. Since the cerebellum is not included in the inflation 
process, Euclidean distances were measured between cerebellar activation foci of penile 
shaft and feet representations. The distance between neighbouring body representa-
tions reflects the amount of cortical space taken up by those representations.22 For 
example, a piano player will have larger digit representations than average, leading to 
a measurably larger distance between the thumb and the little finger. If, for example 
through underuse, the penile shaft representation gets smaller, this should have an ef-
fect on the distance between penile shaft and foot activation foci. 
Table 2. Distances between group penile shaft and foot activation foci in S1 and cerebellum
  Hemisphere Distance (mm)
penile shaft - foot (S1) L 27.5
R 26.8
penile shaft - penile shaft 
(superomedial- inferolateral S1)
L 64.8
R 63.1
penile shaft - foot (Cb) L 20.9*
R 28.1*
Table 2. The distances between penile shaft and foot activation foci in both hemispheres at group level. 
Brain regions in which distances were measured are indicated in brackets. Distances measured in Euclidean 
space are indicated with an asterisk. S1: primary somatosensory cortex, Cb: cerebellum 
DISCUSSION
The present study is the first to investigate genital touch with the extensive field of view 
as supported by 7T imaging, and by doing so it provides novel data on the precise rep-
resentations of the genitalia in the human brain, in particular those of hindbrain areas 
like the cerebellum that were often omitted with other approaches. By exploiting the 
increased BOLD sensitivity and specificity available at 7T, we obtained data with high 
spatial acuity and anatomical specificity. These clearly demonstrate that the genitalia 
are located in the groin region and not below the feet in S1. Furthermore, considerable 
differences were observed in whole-brain activation patterns in response to tactile 
stimulation of the genitalia as opposed to the feet. Tactile stimulation of the penile shaft 
evoked significant activations of discriminative (sensorimotor) and affective (emotional) 
brain regions, whereas tactile stimulation of the feet evoked significant activations of 
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mainly discriminative brain regions. In addition, functional connectivity was assessed 
between activation clusters for both the genitalia and feet. This is the first study to 
report on functional connectivity of genital sensation. 
Some have described the representation of the genitalia to be positioned in the 
medial wall below the representation of the feet in S1,4-6 while others describe a more 
dorsolateral representation between the trunk and leg.7,8 At both single subject and 
group level, our data clearly indicates that the genitalia are represented dorsolateral of 
the feet in S1 (Fig. 1 and Fig. 2), similar to what has been reported by previous studies us-
ing 3T fMRI.7,8 Animal studies investigating genital representations have also described 
this location measuring extracellular recordings in primates23 and more recently using 
cortical microstimulation in rats.24 Despite applying unilateral stimulation to the penile 
shaft, we observed bilateral activation in S1 irrespective of stimulation side. This corre-
sponds well with findings showing that cutaneous regions situated in the midline of the 
body are represented bilaterally in S1.25 Interestingly, studies using electrical stimulation 
of the DNP to locate the genitalia in S1 repeatedly demonstrated activation deep in the 
interhemispheric fissure. Cortical evoked responses elicited by electrical stimulation of 
the DNP were consistently located beneath those elicited by stimulation of the posterior 
tibial nerve.4-6 It should be noted, however, that earlier techniques (e.g. EEG/MEG) used 
to measure brain responses offered poor spatial resolution. In addition, it is known that 
differences in evoked brain potentials can be observed when comparing electrical to 
tactile stimuli, further questioning this method when investigating the processing of 
physiological somatosensory stimuli.26 In the present study, passive tactile stimulation 
of the medial aspect of the feet served as a control, analogous to electrical stimula-
tion of the posterior tibial nerve. We expected to see activation in S1 lateralize in the 
contralateral hemisphere, as can be seen during stimulation of the left foot (Table 1). 
During stimulation of the right foot, however, significant yet weaker activation was also 
observed in the ipsilateral hemisphere (Table 1). Absence of lateralization in S1 has also 
been demonstrated during tactile stimulation of only the right and not the left hand 
in right-handed subjects.27 The authors suggested this asymmetry is associated with 
hand preference and proficiency. Humans not only have a preference for left- or right-
handedness, but also left- or right-footedness which can be seen in for instance football 
players.28 In the present study we did not assess footedness prior to inclusion, however, 
we suggest ipsilateral activation in S1 during stimulation of the right foot may be the 
result of right-footedness. 
Activation in S1 evoked during tactile stimulation of the feet extended anteromedial 
along the postcentral gyrus. Beneath this activation cluster, in most single subjects and 
at group level, activation was also observed deep in the interhemispheric fissure in 
response to tactile stimulation of the genitalia (Fig. 2; medial-view left hemisphere). At 
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a closer examination, this area corresponds to the pMCG and not S1, which had been 
suggested previously.4 
Although it was not the objective of this study, these data also allow a comparison 
of habituation effects during the functional tasks. Inspection of mean signal intensity 
curves superomedial in S1 show comparable habituation between shaft and feet stimu-
lation (Fig. 6), indicating that task saliency was comparable. 
Figure 6. Mean signal intensity (in arbitrary units, a.u.) over time (in seconds, s) superomedial in S1 during 
tactile stimulation of the penile shaft and feet. The stimulation paradigm included 10 blocks (stimulation 
versus rest) each lasting 60 seconds with an additional rest block at the start resulting in a total scan dura-
tion of 620 seconds per task. For viewing purposes, curves were centered around separate baseline values. 
All timeseries were normalized prior to averaging across subjects. The shaded error bars indicate the stan-
dard error over subjects. 
Penile shaft and feet representations showed several areas of overlap (Fig. 1). Cor-
respondingly, in women, overlap has been demonstrated between the genitalia and 
nipple.29 This may have impeded earlier intraoperative mapping experiments by Penfield 
and colleagues, and it may partly clarify why genital sensations were so hard to induce.2 
Furthermore, this finding may also help to provide insight into why electrical therapies 
such as dorsal genital nerve30 and posterior tibial nerve18,19 stimulation share a similar 
inhibitory effect on bladder activity. 
Inferolateral in S1, we observed robust bilateral activation during tactile stimulation of 
the penile shaft and, to a lesser extent, in the left hemisphere during tactile stimulation 
of the right foot. Activation inferolateral in S1 has also been described during electri-
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cal stimulation of the clitoris31 and mechanical stimulation of the rectum suggesting 
this area may be involved in processing pelvic sensory information.32 Furthermore, it 
has been argued that this cluster is in close proximity to the representation of the face 
in S1 and represents stimulus related activation rather than face/mouth movements 
due to discomfort.31 We agree with this observation for the following reasoning. First, 
robust bilateral activation inferolateral in S1 was consistently seen in single subjects and 
the group. Prior to sensory tasks, subjects were instructed to lie still, breathe as they 
normally would and not make any movements. The current stimulus (brushing with a 
toothbrush) was well tolerated by participants and none reported discomfort after the 
scanning procedure. Hence, it is unlikely subjects consequently made similar mouth/
face movements due to discomfort while they were explicitly instructed not to do so. 
Second, inferolateral activation clusters in S1 showed high functional connectivity to the 
superomedial S1 clusters and also other associative sensorimotor areas such as S2, the 
insula and vPMC (Fig. 4). This suggests that activation in this region is related to tactile 
genital stimulation and not due to co-occurring mouth/face movements. 
Bilateral activation of the vPMC was observed during tactile stimulation of the penile 
shaft and unilateral activation of the vPMC was observed in the left hemisphere during 
tactile stimulation of the right foot. In both primates and humans, this area has been 
described to be sensitive to multisensory input, including tactile stimuli.33,34 Accordingly, 
previous studies have demonstrated similar activation of this area during both tactile8 
and electrical31 stimulation of the genitalia. 
Activation of the posterior insula was observed during tactile stimulation of the penile 
shaft and the feet, whereas activation of the anterior insula was only observed during 
genital stimulation. Posterior insula activation has been described earlier and is associ-
ated with gentle touch processing.9,35 Stimulation paradigms used in these studies in-
cluded gentle stroking with a brush, similar to the stroking paradigm with a toothbrush 
in the present study. On the other hand, activation of the anterior insula was observed 
during stimulation of the penile shaft and not the feet. Other cortical areas solely acti-
vated during stimulation of the penile shaft include the pMCG and mPFC. These areas 
have been associated with the processing of affective/emotional properties of touch10,36, 
which fits well with the specific character of sensations (i.e. sexual or erotic) that may 
arise during tactile stimulation of the genitalia as opposed to the feet. In the current 
study, however, we did not assess potential sexual or erotic sensations experienced 
during stimulation making direct correlations not possible. Future research including 
psychometric measurements (e.g. by means of questionnaires) with both arousing and 
non-arousing stimuli is needed to determine whether activation of affective/emotional 
brain regions correlates with the perception of such sensations. 
For the penile shaft, activation was observed posterior in the thalamus in the right 
hemisphere, corresponding to the VPL. In the left hemisphere activation as observed 
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more anteriorly, corresponding to the MD (Table 1). Sensations of touch are processed 
through the dorsal column-medial lemniscus pathway projecting to the thalamus, in 
particular the VPL, and from thereon to the somatosensory cortex.20 Our findings sug-
gest the MD nucleus is also involved in processing genital touch. Accordingly, activation 
was also observed in the mPFC, where MD afferents project to.20 In addition, electro-
physiological studies in cats and rats have identified multiple bilateral subregions of 
the thalamus receiving inputs from the genital tract, including the VPL and MD.24,37 Here, 
unilateral activation of the VPL in the left hemisphere and MD in the right hemisphere 
may, however, be the result of the small cluster size and weak BOLD signals measured 
in the thalamus using the current whole-brain acquisition protocol (Table 1). On the 
other hand, for the left foot, contralateral VPL activation was observed and for the right 
foot bilateral VPL activation was observed. Accordingly, contralateral S1 activation was 
observed for the left foot and bilateral S1 activation for the right foot. 
Here we also mapped the representation of the penile shaft and feet in the ante-
rior and posterior lobes of the cerebellum (Fig. 3). In line with previous findings, tactile 
stimulation of the feet evoked ipsilateral activation in lobule IV.38,39 In some single 
subjects, activation was also observed more posterior in the cerebellum in both ipsilat-
eral and contralateral hemispheres. At the group level, sparse activation was observed 
only in the contralateral hemisphere. We expected the genitalia would be represented 
just posterior to the feet in lobule IV, supporting previous fMRI studies in humans 
describing a somatotopical layout of the body in the anterior lobe of the cerebellum 
orientated anterior-posteriorly.38-40 Surprisingly, in most single subjects and at the group 
level, genital representations were found more posterior in lobule VI in both cerebellar 
hemispheres (Fig. 3), seemingly posterior to the cerebellar hand representations.40 In 2 
individuals (#11, #13), activation was also observed adjacent to the feet representations 
in lobule VI, where we would have expected the genitalia to be represented. In these 
subjects, though, we also observed activation more posterior in lobule VI. When com-
paring cerebellar representations to those found in S1, the feet representations found 
anterior in lobule IV appear to be part of the somatomotor network41 also including the 
superomedial S1 feet and shaft representations. In contrast, the shaft representations 
found posteriorly in lobule VI may be part of a more associative frontoparietal network41 
also incorporating the inferolateral S1 cluster. 
In the present study, timeseries from cerebellar clusters showed low functional 
connectivity to any of the other ROIs. Regions that showed the highest degree of con-
nectivity were the inferolateral S1 and vPMC in the right hemisphere. When inspecting 
the topographic organization of cerebrocerebellar circuits based on intrinsic functional 
connectivity, lobule VI is largely mapped to the inferolateral S1 and vPMC.41 Our data 
suggest that these cerebellar representations of the genitalia in lobule VI belong to 
this particular cerebrocerebellar network. The relatively low functional connectivity 
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demonstrated here may be the result of methodological differences such as task-based 
functional connectivity vs resting-state connectivity and sample sizes N=9 vs N=1000. 
Functional connectivity was assessed for both functional tasks, no previous studies 
have reported on this. For the penile shaft, this was mainly done to see if we could 
demonstrate separate cerebral networks involved in processing genital touch (i.e. 
discriminative vs affective). Brain regions such as superomedial and inferolateral S1, S2, 
vPMC, the posterior insula and right anterior insula showed high functional connectivity 
to each other. On the other hand, the pMCG, left anterior insula and cerebellum showed 
low overall connectivity to other brain regions. Interestingly, for the feet, superomedial 
S1 representations showed high connectivity with S2 and the posterior insula on the 
ipsilateral side, whereas connectivity with S2 on the contralateral side was low. This 
suggests that, although bilateral activation of S2 was observed, there is some lateral-
ization and dominance of the contralateral S2. Moreover, we observed high functional 
connectivity between the posterior insula and S2 in the same hemisphere, which is in 
accordance with the finding that these cortical areas are reciprocally connected.42 
We acknowledge, however, that the task-based functional connectivity analysis in our 
study does not give a measure of intrinsic connectivity of neural networks in contrast to 
resting-state fMRI. In addition, measures of functional connectivity demonstrated here 
are related to our stimulation paradigm (i.e. brushing with a toothbrush). Other studies 
using different stimulation paradigms to investigate genital touch may produce differ-
ent connectivity patterns. 
The use of ultra-high field (7T) fMRI here provided considerable benefits compared to 
neuroimaging techniques used in previous studies investigating genital touch such as 
EEG, MEG and 3T fMRI.4-8 Due to significant gains in SNR at 7T, we were able to acquire 
data with much higher spatial resolution (1.77 x 1.77 x 1.75 mm3), unmatched by previous 
studies. Furthermore, while no direct comparisons were made, it is plausible 7T fMRI 
offers increased BOLD sensitivity and allows detection of smaller effects facilitating in-
creases in statistical strength when conducting both single subject and group analyses 
compared to fMRI at lower field strengths (1.5- & 3T).17,43 On the other hand, the relative 
contribution of physiological noise also increases at higher field strengths. 7T fMRI for 
instance, is more susceptible to false positive activation caused by subject head mo-
tion, potentially leading to higher exclusion rates in comparison to fMRI at lower field 
strengths. By employing a multiband EPI-sequence, whole-brain coverage including the 
cerebellum was achieved whilst preserving high spatiotemporal resolution. The current 
study is the first investigating genital sensation with such an extensive field-of-view and 
thereby the first to report on cerebellar representations of male genital sensation. This 
achievement may partly result from the fact that we placed a dielectric pad containing 
CaTiO3 posterior of subjects’ heads, which has been shown to increase both cerebellar 
T1-weighted anatomical coverage and detection of T2*-weighted BOLD signals.44 
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Conclusion
In conclusion, using 7T fMRI, we present neural representations of genital sensation with 
unprecedented spatial resolution and whole-brain coverage in both single subjects and 
the group. We clearly show the genitalia are represented in the groin region in S1 and not 
below the feet. Whole-brain responses and additional connectivity analyses revealed that 
passive penile stimulation evoked significant activation in brain regions that can be seg-
regated from those associated with feet stimulation. Genital sensations are processed in 
both sensorimotor and affective brain regions, whereas feet sensations are processed in 
sensorimotor regions. These differences may contribute to the specific character of sensa-
tions (i.e. sexual or erotic) that are associated with stimulation of the external genitalia. 
MATERIALS AND METHODS 
Subjects
This study was conducted in agreement with the principles specified by the Declaration 
of Helsinki. Approval for the current study was given by the Medical Ethics Committee 
of the Erasmus Medical Center Rotterdam (METC 2015-451). All subjects provided writ-
ten informed consent before entering the study. 17 healthy right-handed male subjects 
(mean age ± SD: 29.6 ± 7.8 years) participated in this study. Subjects were asked to take 
off their trousers and placed in a supine position on the MRI-bed. 
Stimuli and functional paradigm
All subjects completed the same scanning protocol, consisting of functional runs 
followed by a T1-weighted anatomical scan of the whole-brain for co-registration of 
functional data. Two sensory tasks were performed using a block paradigm. These tasks 
included subjects undergoing tactile stimulation of the penile shaft and medial aspect 
of the left and right foot. During both runs, an experimenter was positioned at the 
entrance of the scanner bore. Tactile stimulation was delivered using a commercially 
available toothbrush attached to a stick. The experimenter received audio cues indicat-
ing when and where to brush on MR-compatible headphones, generated in MATLAB 
using the Psychophysics Toolbox Version 3 (http://psychtoolbox.org/). The left and right 
penile shaft were brushed for a duration of 20 s respectively, followed by 20 s of rest (no 
brushing). This sequence was repeated 10 times with an additional rest period of 20 s at 
the start of both runs, resulting in a total scan time of 620 s per run. Brushing was done 
in a proximal to distal direction at a frequency of approximately 1Hz and performed by 
the same experimenter for all subjects to minimize inter-subject stimulation variability.13 
For this study, a toothbrush was used to deliver tactile stimulation with the aim to mimic 
a physiological stimulus without inducing sexual arousal. The brushing of a toothbrush 
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is a good alternative for human touch7,45 and can comfortably be executed while stand-
ing at the entrance of the scanner bore. Subjects were given a towel which they were 
instructed to place on the abdomen. Subsequently, subjects were instructed to place 
the penis on the towel in order to prevent skin-to-skin contact with the thigh and ab-
domen during the tactile stimulation. Prior to the actual scanning session, all subjects 
underwent a training session in a mock scanner. This gave subjects the opportunity to 
get acquainted with the tactile stimulus (brushing of a toothbrush). During this training 
session, tactile stimulation was delivered in a similar manner as described above.
Data acquisition
All functional and structural data were acquired on a 7T MRI scanner (Philips Achieva) 
using a volume transmit coil and a 32-channel receive coil (Nova Medical). Functional 
data was acquired using a multiband echo planar imaging (mb-EPI) sequence with 
multiband factor 2. Whole-brain coverage, including the anterior lobe of the cerebellum, 
was achieved using the following parameters: voxel size 1.77 x 1.77 x 1.75 mm3; matrix 
size: 104 x 127; FOV = 184x223 mm2; number of slices: 70; TR/TE = 2000/25 ms; flip angle 
= 70°; in-plane SENSE factor R = 3. Whole-brain anatomical data was acquired using the 
MPRAGE sequence with the following parameters: voxel size 0.7 x 0.7 x 0.7 mm3, matrix 
size: 352 x 353, FOV = 246 mm; number of slices: 249; TR/TE = 4.4/1.97 s, SENSE factors R = 
1.6 (anterior-posterior) and R = 1.5 (right-left); total acquisition time 8’35”. In addition, to 
account for signal loss in infratentorial areas, a dielectric pad containing calcium titanate 
(CaTiO3)46 was placed posterior of the subjects’ heads.46 
Image preprocessing
All data was reconstructed on an offline workstation using dedicated reconstruction 
software (ReconFrame, Gyrotools, Zürich, Switzerland). Further data processing was 
done in SPM12 (Wellcome Trust Center for Neuroimaging, London, UK). Pre-processing 
steps included joint image realignment of all four functional runs, co-registration of the 
anatomical image to the resulting mean functional image and smoothing of functional 
data with a Gaussian kernel (FWHM 2.5 mm). For the extraction of peak activation coor-
dinates, functional data was normalized to the standardized brain template of the Mon-
treal Neurological Institute (MNI). Additionally, inflated cortical surfaces were created 
in Freesurfer (http://surfer.nmr.harvard.edu/) using single subject anatomical images 
and the MNI template. In order to aid the inflation process, all images were first bias 
corrected (bias FWHM = 18, sampling distance = 2) and resliced to 1mm isotropic in SPM. 
Whole-brain analyses
First level statistical analysis was conducted using the General Linear Model (GLM). Each 
functional task was modeled as a boxcar convolved with a canonical hemodynamic re-
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sponse function (HRF) and temporal derivative as basis functions. Realignment param-
eters were added as nuisance regressors to account for confounding motion effects. The 
response for each task was estimated independently from the others. Activation maps 
for tactile stimulation of the left and right penile shaft showed a high degree of overlap 
in both hemispheres, and were therefore conjoined into a single contrast using a global 
null conjunction analysis47 thresholded at p < 0.05 voxel-based FWE). Activation maps 
for tactile stimulation of the left and right foot were generated as separate contrasts and 
thresholded at p < 0.05 FWE. 
Second level statistical analysis was conducted using a one-sample t-test on individu-
als’ task responses. Likewise, at group level, left and right shaft contrasts were conjoined 
using a global null conjunction analysis p < 0.005 uncorrected for multiple comparisons. 
Activation maps for tactile stimulation of the left and right foot were again thresholded 
at p < 0.005 uncorrected for multiple comparisons. Both single subject and group level 
cortical activation maps were projected on inflated cortical surfaces created in Free-
surfer and sampled halfway the mid-cortical depth in order to avoid vascular artifacts at 
the pial surface. 
Functional connectivity analyses 
To further evaluate activation of different networks (i.e. discriminative vs affective), we 
computed the correlation between timeseries from different ROIs in single subjects. 
Timeseries were extracted from individual pre-processed contrast images, which were 
realigned, co-registered and smoothed as described earlier. For the penile shaft, ROIs 
included were S1, S2, vPMC, posterior and anterior insula, pMCG and the cerebellum. 
ROIs were isolated using individuals’ contrast images and successfully identified in 9 out 
of 13 individuals. Activation in the thalamus and mPFC could only be observed in 4 and 
5 subjects respectively, and were therefore not included in the functional connectivity 
analysis. For the feet, included ROIs were the S1, S2, posterior insula and cerebellum. 
Again, ROIs were isolated using individuals’ contrast images and were successfully iso-
lated in 10 out of 13 individuals. Overlapping activation clusters were manually separated 
in ITK-SNAP (http://www.itksnap.org/). Subsequently, voxel timeseries were extracted 
from each ROI per single subject and denoised for signal arising from white matter, 
gray matter and cerebrospinal fluid using linear regression. Connectivity was defined as 
the linear correlation between timeseries of different ROIs, which was computed with 
the Pearson’s correlation coefficient. Single subject correlation matrices were used to 
compute a mean correlation matrix for both the penile shaft and feet.
Data availability
The datasets analyzed during the current study are available in NIFTI format for inter-
ested researchers. Please contact the corresponding author to make a request.
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ABSTRACT
Aim: The aim of this study is to evaluate the acute effects of sacral neuromodulation 
(SNM) on various urodynamic parameters. 
Methods: Patients with overactive bladder (OAB) and detrusor overactivity (DO) who 
were planned for percutaneous nerve evaluation (PNE) were included. Directly after the 
PNE a urodynamic study (UDS) was performed. The stimulation was turned off during 
the first UDS (UDS 1), and during the second filling cycle, stimulation was turned on 
(UDS 2). The UDS was followed by a test phase of one week and the bladder diaries 
were evaluated during an outpatient clinic visit. Primary outcome measures were the 
differences in UDS parameter values with SNM off and on. 
Results: Ten female patients were included in the study and completed the study pro-
tocol. Eight patients showed ≥50% improvement of symptoms following a test phase. 
There were no differences between UDS 1 and UDS 2 in the UDS parameters: Bladder 
volume at first sensation, bladder volume at first DO, highest DO pressure, bladder 
capacity, maximum flow rate (Qmax) and pressure at maximum flow rate (pQmax). 
Discussion: None of the above mentioned urodynamic parameters was influenced by 
acute sacral neuromodulation in patients who responded to sacral neuromodulation. To 
the best of our knowledge this is the first study investigating the acute effects of SNM 
on bladder function. 
Keywords: urodynamics, neuromodulation, sacral root, overactive bladder, acute effect
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INTRODUCTION
Overactive bladder (OAB) is a condition defined as urgency, with or without urgency 
urinary incontinence, usually associated with frequency and nocturia.1 The prevalence 
is described to be between 11 – 16% worldwide and is expected to increase as a result of 
the aging of the population causing a high burden on society.2,3 The pathophysiology of 
this highly prevalent disease is still being explored and the value of urodynamics (UDS) 
in OAB is investigated. About 54.2% of patients with symptoms of OAB show detrusor 
overactivity on UDS.4 
Currently, first-line treatment consists of conservative treatments like pelvic floor 
muscle therapy (PFMT) and second-line treatment of oral anticholinergics or betami-
metics. Neither of these treatments is very efficient. Research shows that the benefit of 
PFMT is not maintained on the long term and more than 50% stop anticholinergic drug 
treatment within the first three months because of lack of benefit and adverse effects.5 
Sacral neuromodulation (SNM) is a safe and effective third line therapy for symp-
toms of OAB.6 SNM is supposed to suppress involuntary bladder contractions and to 
normalize bladder sensation via afferent nerve modulation.7 Prior to implantation of a 
sacral neuromodulator, a percutaneous nerve evaluation (PNE) or first stage tined lead 
placement test (FSTLP) is done to evaluate the efficacy in the OAB patient. In patients 
with an improvement of ≥50% of symptoms, evaluated with bladder diaries, a sacral 
neuromodulator is implanted.5 
Different properties of SNM in bladder dysfunction have been investigated; such as 
the onset of action, the wash-out period and the effectiveness of intermittent and on-
demand SNM.8-11 An argument for intermittent or on-demand SNM was a longer battery 
life, and consequently fewer surgical replacements, although the need for intermittent 
SNM is less urgent since the introduction of the rechargeable battery.12 In some studies 
it was found that efficacy of SNM decreased after 5 years.13 Adaption by the nervous 
system was postulated as the cause of this.10,14 Other studies found that the therapeutic 
effect of SNM was stable after 5 to 6 years.6,15 
Implantable ultrasound devices and potentiometers to detect bladder filling and 
contractions have been studied in pigs.16,17 Such devices could be helpful in the develop-
ment of a feedback system in which the neuromodulator automatically activates when 
the detrusor pressure is increasing.18 If acute SNM has direct inhibitory effects on bladder 
function, such a closed-loop feedback system could be of potential value for patients 
with OAB. Studies in rats demonstrated an acute inhibitory effect of neuromodulation 
on bladder contractions.19 
Whether UDS parameters can predict the success of SNM in patients has been inves-
tigated, but no predictive UDS parameters have been found.20,21 Moreover, when com-
paring UDS parameters before and during SNM (six months stimulation), several UDS 
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parameters significantly changed; bladder volume at first sensation, bladder capacity, 
maximum detrusor pressure and Qmax.22-24 The acute effect of SNM on UDS has never 
been investigated. 
Therefore, the aim of this study is to evaluate the acute effect of SNM on the different 
UDS parameters. 
MATERIALS AND METHODS
The present study was approved by the local medical research ethics committee (METC 
2017-471). Prior to the study, written informed consent was obtained from all patients. 
Patients
Patients with OAB and urodynamically proven detrusor overactivity, who were sched-
uled for PNE, were eligible for screening. Exclusion criteria were age under 18 years, 
intravesical botulinumtoxinA injections in the past 9 months, predominant stress 
urinary incontinence, bladder pain syndrome, neurogenic bladder, urinary tract infec-
tion, having an indwelling catheter, previous radiotherapy of the pelvis, pregnancy and 
malignancies of the lower urinary tract. 
Intervention
Our standard care procedure for PNE was performed and is as follows. All anticholiner-
gics and β3-adrenoceptor-agonists were stopped two weeks prior to the PNE. The PNE 
is done in the outpatient clinic under local anesthesia. PNE’s were performed using the 
PNE-sets of Medtronic (4 patients) or Axonics (6 patients). A test electrode is inserted 
into one of the S3 foramens of the sacrum. Placement is considered correct if stimula-
tion is felt in the vagina, penis, perineum or anus. The electrode is then connected to 
the external nerve stimulator (ENS). In the current study, the patient underwent a 
urodynamic study (UDS 1) after placing the electrode but before the ENS was turned 
on. This study was performed according to ICS criteria, using a 7 Fr transurethral double 
lumen catheter and an 8 Fr rectal pressure sensor.25,26 The bladder filling rate was 50 
ml/min. The patient was asked to indicate the first sensation of bladder filling, the first 
desire to void and the moment of a strong desire to void. Permission to void was then 
given. Post void residual volume was determined through the catheter. Next, the ENS 
was turned on with the stimulation amplitude just above the sensory threshold and 
the pulse width and frequency set at 210 usec and 14 Hz, respectively. The urodynamic 
study was then repeated (UDS 2). The patients were given antibiotics for three days to 
prevent urinary tract infections following the urodynamic study. After the urodynamic 
study, the standard procedure was resumed, that is, the patient completed a bladder 
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diary which was evaluated after one week. The PNE was considered positive if at least 
50% improvement was obtained in at least one of the symptoms (frequency, voided 
volume or incontinence episodes). In case the PNE was inconclusive, a first stage tined 
lead placement test (FSTLP) was proposed in which the permanent lead is placed in 
one of the S3 or S4 foramens and is connected to an external stimulator. Stimulation 
parameters were the same as during PNE. This test phase has a duration of about one 
month and the evaluation of success is done on the basis of bladder diary results of at 
least three days, which is comparable to the PNE evaluation. 
Outcome measures
Demographic data, data from bladder diaries and the results of the PNE and FSTLP, were 
extracted from the medical record (Table 1). The outcome measures were various UDS 
parameters as given in Table 2. The results of three different UDS were compared: UDS 
B (performed at baseline, prior to the PNE, as a part of our standard procedure of care), 
UDS1 (after the PNE, without stimulation) and UDS2 (after the PNE, with stimulation). 
During UDS B two filling - voiding cycles were performed. Of these two cycles, the data 
of the filling phase with the highest filled volume and the data of the voiding phase with 
the highest maximum flow rate were used in the current study. 
Statistical analysis 
All statistical analyses were done with the Wilcoxon rank test for non-parametric related 
samples, using SPSS version 24.0 (IBM Corp., Armonk, NY, USA). 
RESULTS
A total of 10 female patients with a mean age of 59 (interquartile range 54-63) years 
were willing to participate and completed the study protocol, see Table 1 for patient 
characteristics. All patients had OAB for at least 2 years with proven detrusor overactiv-
ity on UDS B. All patients except for one (patient 9) also showed detrusor overactivity 
during UDS 1 and UDS 2. The PNE was positive in 4 patients, inconclusive in 4 patients 
and negative in 2 patients (patient 2 and 9). The 4 patients with an inconclusive result 
reported to feel stimulation during UDS 2 but lost sensation after 2 to 4 days, possibly 
due to displacement of the lead. An FSTLP was next done, with a positive outcome in 
all 4 patients. Consequently, a permanent neuromodulator was implanted in 8 patients. 
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Table 1. Patient characteristics
N
Male/Female 0/10
Age during PNE, in years median (IQR) 59 (54 – 63)
Frequency/24 hours, median (IQR) 13 (11 – 15)
Nocturia episodes, median (IQR) 4 (2 – 6)
Incontinence episodes, median (IQR) 3 (1 – 5)
Pad use/24 hours, median (IQR) 3.5 ( 1 – 5 )
Functional bladder capacity in ml, median (IQR) * 246 (125 – 400) 
Overactive bladder
- Wet 9 
- Dry 1 
Concomitant bladder problems
- Mixed incontinence 3 
Therapies before PNE
- Pelvic floor muscle therapy *  4 
- Anticholinergics 10 
- TENS/PTNS *  4 
- OnabotulinumtoxinA * 3 
* data of one patient was incomplete
IQR = interquartile range, TENS: transcutaneous electrical nerve stimulation, PTNS: Percutaneous Tibial 
Nerve Stimulation, PNE: percutaneous nerve evaluation
The median UDS 1 and UDS 2 parameters of the positively responding 8 patients are 
shown in Table 2. No statistically significant differences were found between UDS 
parameters without stimulation (UDS 1) and with stimulation (UDS 2). Figure 1 shows 
UDS parameters during filling phase, three data points are shown; UDS at baseline, 
UDS directly after the PNE without stimulation (UDS 1) and UDS directly after PNE with 
stimulation (UDS 2). The lines represent the 8 positively responding individuals and their 
median. In the outcome parameter “bladder volume at first sensation” 4 lines are missing. 
These patients did not indicate when the first sensation was notified. UDS parameters 
of the voiding phase are shown in Figure 2. The maximum flow rate and the pressure at 
maximum flow rate did not change significantly comparing UDS 1 and 2, also shown in 
Table 2. 
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Table 2. UDS parameters of UDS 1 and 2.
UDS 1 UDS 2 P value*
Filling phase
Bladder volume at 1st sensation
IQR
157 ml
(89 – 290)
115 ml
(63 – 147)
.854
Bladder volume at 1st DO
IQR
184 ml
(110 – 300)
179 ml
(125 – 340)
.263
Highest DO pressure
IQR
32 cmH2O
(21 – 35)
32 cmH2O
(21 – 35)
.574
Bladder capacity in ml
IQR
175 ml
(79 – 518)
190 ml
(160 – 364) 
.401
Micturition phase
Maximum flow rate
IQR
12 ml/s
(10 – 17)
10 ml/s
(6 – 14)
.462
Pressure at maximum flow
IQR
31 cmH2O
(26 – 43)
31 cmH2O
(27 – 39)
.089
*Wilcoxon Signed Rank Test for non-parametric related samples
UDS = Urodynamic study
IQR = Interquartile range
DO = Detrusor Overactivity
Figure 1. Urodynamic parameters of the filling phase of UDS B, UDS 1 and UDS 2. 
Abbreviations: DO: Detrusor overactivity 
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Figure 2. Urodynamic parameters of the voiding phase of UDS B, UDS 1 and UDS 2. 
DISCUSSION
To our best knowledge, this is the first study that suggests that sacral neuromodula-
tion has no significant acute effect on standard UDS parameters in patients with OAB in 
whom SNM is eventually an effective treatment. This accounts for both the filling phase 
and the voiding phase. The figures show that besides the median change of the param-
eters, the individual changes are also limited. These results are complementary to results 
of previous studies. Significant changes in UDS parameters were demonstrated after six 
months of SNM in patients with DO for both the filling and the voiding phase; the blad-
der volume at first sensation increased, the bladder capacity increased, the maximum 
detrusor pressure during the filling phase decreased and the Qmax increased.22-24 
The working mechanism of SNM is still being investigated, but at present, it is be-
lieved that SNM activates afferent pathways modulating several brain areas which in 
turn regulate bladder control. Differences between acute and chronic SNM in regional 
cerebral blood flow (rCBF) have been demonstrated using PET.7 When acute SNM is ap-
plied, brain areas predominantly involved in sensorimotor control, showed an increase 
in rCBF.7 Moreover, during acute SNM, Blok et al. described a change of rCBF in the insula. 
These authors argued that this might cause activation of the sympathetic system, which, 
in turn, results in an increase in the bladder capacity.7 The bladder capacity was not 
measured during this PET study. The current study did not demonstrate an increase in 
bladder capacity after acute SNM. In contrast to us, the study of Opisso et al. did show 
such an increase. They used subject-controlled dorsal genital nerve stimulation (DGN) 
in patients with neurogenic bladders due to partial spinal cord injury, multiple sclerosis 
or traumatic brain injury.27 Subjects could turn on the stimulator as soon as they felt 
urgency during bladder filling. However, the underlying mechanisms of bladder dys-
function in neurogenic and idiopathic patients are not comparable.28 In the present 
study only patients with idiopathic OAB were included. 
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During chronic stimulation, when SNM has been active for 6 months, changes in the 
rCBF in brain areas involved in attention and alertness were detected.7 This, in turn, 
would result in less firing of the pontine micturition center (PMC) and restore bladder 
function. The fact that this rCBF change in the brain areas involved in attention and 
alertness is only detected after chronic SNM and not after acute SNM might be related to 
the working mechanism of SNM and could explain the differences in results in UDS be-
tween acute and chronic stimulation. The areas predominantly involved in sensorimotor 
control showed a decrease in rCBF after chronic stimulation, instead of the increase in 
rCBF after acute SNM. This change might also explain the differences in results in UDS 
between acute and chronic stimulation. 
The wash out duration of SNM has been investigated. Cadish et al. found a mean of 
11.25 days before return of symptoms after turning the SNM off in 12 women with OAB.8 
Altomare et al. detected that in 19 patients with urinary incontinence or fecal incon-
tinence, the mean time to recurrence of symptoms after turning the SNM off was 3.4 
months (range 0.9 – 13.5) and in 9 patients symptoms never returned.9 In conclusion, 
chronic effects of SNM seem to be maintained some time after stimulation is stopped, 
suggesting neuroplasticity of the involved brain areas. Moreover, the onset of action of 
SNM was recently investigated using bladder diaries which indicated that the mean time 
to 50% or greater symptom improvement was 3.3 days.29 
These results, and those of the current study, suggest that a closed-loop feedback 
system, which activates SNM automatically when the detrusor pressure increases, would 
not be effective due to lack of acute effects after such short stimulation. However, on-
demand and intermittent neuromodulation have been proved to be effective therapies 
in two separate trials.11,14 A possible explanation might be that in both trials, the patients 
were already using the SNM for > 7 years and 48 months, respectively.11,14 The above 
described neuroplasticity of the involved brain areas might already have been utilized, 
indicating that hypothetically, these neuroplastic changes can be maintained by inter-
mittent or on-demand neuromodulation. Suggestions for future research in the use of 
a feedback neuromodulation system would be to investigate it with patients who are 
long-term users and who are starting users of SNM. 
The main limitation of the current study is its small sample size. We initially aimed at a 
larger sample size. However, considering the absence of statistically significant findings 
in 8 successfully tested patients and the invasiveness of the UDS, we decided to stop 
inclusion for ethical reasons. In 4 patients, the first sensation of bladder filling was not 
noted because they had an involuntary detrusor contraction followed by direct urine 
leakage and micturition. Four patients had undergone a FSTLP after the PNE because of 
inconclusive PNE results. This inconclusive PNE was most likely caused by lead migration 
as all 4 patients described a loss of sensation of stimulation of stimulation after some 
days. Lead migration is a known disadvantage of PNE compared to a FSTLP and might be 
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the cause that PNE is a less sensitive screening method than FSTLP.30 In our hospital, OAB 
patients first undergo a PNE, in case this is inconclusive, a FSTLP is conducted. The influ-
ence of this on our study results is considered minimal, since all four patients reported 
to feel stimulation during the UDS 2 at the same location as during placement of the 
PNE lead. Moreover, the stimulation parameters used during PNE and FSTLP were the 
same (frequency 14 Hz and pulse width 210 μs). Ultimately, for this study, it was merely 
of relevance whether or not the patient is a responder to sacral neuromodulation in 
general. The method of testing is of secondary importance. 
In conclusion, this study suggests that there are no acute effects of SNM on conven-
tional UDS parameters. More studies are needed to confirm this finding and further 
elucidate the role of factors such as gender, age and etiology of OAB. 
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ABSTRACT
Aims: The OAB-q SF evaluates both symptom bother and health-related quality of life in 
patients with overactive bladder, a highly prevalent disease. The objective of this study 
was to translate and validate a Dutch version of the OAB-q SF.
Methods: The translation into Dutch and validation process of the OAB-q SF was 
performed according to standardized guidelines. Patients with overactive bladder who 
visited the department of Urology outpatient clinic completed the questionnaires OAB-
q SF, EQ-5D-5L, UDI-6 and the ICIQ-OAB at baseline (test) and two weeks later (retest). 
A reference group from the department of Allergology outpatient clinic completed the 
same questionnaires once. The evaluated measurement properties included content 
validity, internal consistency, reproducibility, criterion validity and construct validity.
Results: Fifty-two patients were included in the study group and 51 references were 
included. The content validity was adequate and the internal consistency was excel-
lent (Cronbach’s alpha > 0.80). The reproducibility was good with intraclass correlation 
coefficients higher than 0.70. Patient’s OAB-q SF scores were moderately to strongly 
correlated with the UDI-6, ICIQ-OAB and the EQ-5D-5L confirming the criterion validity. 
A good construct validity was demonstrated with significant higher scores of the OAB-q 
SF score in patients compared to references. 
Conclusions: The Dutch OAB-q SF is a reliable and valid measure to evaluate symptom 
bother and health-related quality of life in patients with overactive bladder. 
Keywords: Patient Reported Outcome, Questionnaire, Overactive Bladder, Urgency, 
OAB-q SF, Validation, Translation
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INTRODUCTION
Overactive bladder (OAB) is defined as urgency, with or without urgency urinary inconti-
nence, usually associated with frequency and nocturia. The prevalence of this condition 
is described to be between 13 – 16 % worldwide, and is expected to increase as a result 
of the aging of the population. It has been shown to have a great negative impact on 
an individual’s health-related quality of life (HRQOL). All this causes a high burden on 
society.1-3
OAB is a symptom-based condition, with low positive and negative predictive val-
ues for urodynamic investigations.4,5 The best method available to diagnose disease, 
quantify disease severity and evaluate treatment effects is therefore the use of patient 
reported outcome’s (PROs), usually in the form of a questionnaire. Since the introduction 
of PROs, many different questionnaires have been developed. In order to compare the 
burden of OAB in patients and define guidelines for treatment, consensus is necessary 
on the specific questionnaire to use. The EAU (European Association of Urology) and the 
ICS (International Continence Society) guidelines do not recommend specific question-
naires to use for OAB, but both professional organizations mention that it is important 
to use questionnaires validated in the language of use.6,7 The International Consortium 
for Health Outcome measurements (ICHOM) aims to improve value-based healthcare by 
defining global standard sets of outcome measures for different conditions. A core set of 
outcome measures for OAB which includes the OAB-q SF questionnaire, was developed 
in 2017.8 
The OAB-q Short Form (SF) is a worldwide used questionnaire for health-related qual-
ity of life in patients with OAB. OAB-q SF is the shorter version of the 33-item “OAB-q” 
questionnaire. The OAB-q SF includes 19 items; a 6-item symptom bother scale and a 
13-item health-related quality of life (HRQOL) scale.9,10 
Before implementing the ICHOM set of outcome measures for OAB in the Netherlands, 
the OAB-q SF questionnaire needs to be translated and validated in Dutch. Therefore the 
aim of this study is to translate and validate the OAB-q SF in the Dutch language. 
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MATERIALS AND METHODS
Study design
This is a single-center, prospective cohort validation study, for which approval was 
obtained by the Ethics Review Board.
Patient group
All patients seen at the Urology outpatient clinic in between April 2018 and February 2019 
diagnosed with OAB were eligible for screening. OAB was defined as urinary urgency, 
with or without urinary incontinence. Inclusion criteria were age ≥18 years and being flu-
ent and literate in the Dutch language. Exclusion criteria consisted of urinary diversions, 
a history of/or active malignant tumors of the urinary tract, hematuria, bladder stones, 
neurogenic bladder, dementia, mental retardation and symptomatic urinary tract infec-
tion. The treating physician explained the study to patients eligible for inclusion and 
invited to participate. After signing informed consent patients were asked to complete 
the questionnaires during the inclusion visit (test) and 2 weeks later at home (retest). 
Characteristics of the included patients were extracted from the medical records. 
Reference group
Patients who visited the department of Allergology outpatient clinic between Septem-
ber 2019 and December 2019 were invited as reference group. Inclusion criteria were 
age ≥18 years and being fluent and literate in the Dutch language. Exclusion criteria 
consisted of a urological medical history or current bladder problems, dementia and 
mental retardation. We considered these patients as a proper control group as allergy 
pathology has no relationship with bladder problems; those with bladder problems 
were indeed not eligible for inclusion in the reference group. Patients who met inclusion 
criteria were informed by their treating physician and if willing to participate, informed 
consent was signed and one set of questionnaires was completed. 
Questionnaires
The questionnaire set included 4 questionnaires: the OAB-q SF, the EQ-5D-5L, the Uro-
genital Distress Inventory 6 (UDI-6) and the International Consultation on Incontinence 
Questionnaire Overactive Bladder (ICIQ-OAB). 
- The OAB-q SF is a 19-item, self-administered disease specific instrument derived 
from the OAB-q.9,10 The OAB-q SF contains two main subscales: Symptom bother (6 
items) and Health Related Quality of Life (HRQOL, 13 items). Each item is rated on 
a six-point Likert scale, for the symptom bother scale ranging from 0 (not at all) to 
6 (a very great deal) and for the HRQOL scale from 0 (none of the time) to 6 (all of 
the time). The two subscales are separately summed and, on the guidance of the 
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scoring manual,9 transformed into scores ranging from 0 to 100. A higher score on 
the symptom bother scale indicates a greater symptom severity and a higher score 
on the HRQOL scale indicates a better HRQOL, so they are inversely related to each 
other. These two scores, are always be mentioned separately, since the OAB-q SF has 
no total score. 
- The EQ-5D-5L questionnaire (European Quality of life 5-Dimension 5-Level question-
naire) developed by the EuroQol group, is one of the most used PRO instruments for 
the measurement of HRQOL.11 It consists of 5 questions addressing mobility, self-care, 
activities, pain/discomfort and anxiety/depression, the answers are transformed to 
an index value ranging from 0 (inability) to 1 (no problems) by using the accessory 
index value calculator. In addition, the health state is self-reported by completing a 
visual analogue scale (VAS) ranging from 0 “the worst health you can imagine” to 100 
“the best health you can imagine”. 
- The UDI-6 is a six-item symptom inventory, specific to symptoms associated with 
lower urinary tract dysfunction. It combines information on irritative, stress and 
obstructive/discomfort symptoms of the lower urinary tract.12 This questionnaire 
has been translated and validated in Dutch and the mean score of the six items is 
converted to a 0-100 scale on the guidance of the scoring manual.13 
- The ICIQ-OAB questionnaire indicates the symptom bother of frequency, nocturia, 
urge and incontinence in 4 questions. The impact on quality of life of these four 
problems is self-reported by completing four bother scales from 0 to 10. According 
to the design of the questionnaire the results of the ICIQ-OAB questions are summed 
creating a score; ICIQ-OAB Q questions. Furthermore, in the present study the bother 
scales are summed; ICIQ-OAB BS (bother scales), creating a value ranging from 0 to 
40 indicating the HRQOL. The design of the questionnaire does not indicate how to 
calculate the total score of the bother scales.
Cross-cultural adaption
The cross-cultural adaption of the original English OAB-q SF into the Dutch language was 
done according to the standardized guidelines for linguistic validation.14 The forward-
translation of the English OAB-q SF into the Dutch OAB-q SF was performed by three 
professional native Dutch-speaking translators separately. During a consensus meeting 
discrepancies between the three translations were discussed with the translators, two 
urologists (BB and JS) and the primary investigator (IG). The final version (see supple-
mentary material) was backward-translated by a native English-speaking translator. 
To confirm the content validity of the Dutch version, the questionnaire was evaluated 
face-to-face with 5 patients visiting the Urology outpatient clinic. 
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Measurement properties
Content validity
The content validity was assessed during the linguistic validation by patient and research-
ers (IG, BB and JS). Researchers subjectively evaluated the correspondence between the 
clinical symptoms of OAB and the questions. Patients reported on the formulation of the 
questions and clarity of the questions during the face-to-face evaluation. 
Internal consistency
By assessing the correlation between different items within the questionnaire, the 
internal consistency is examined, demonstrating whether the items measure the same 
underlying construct. The Cronbach’s alpha was calculated for the two subscales of the 
OAB-q SF. A Cronbach’s alpha between 0.70 and 0.95 was considered to reflect adequate 
internal consistency.15 
Reproducibility
The reproducibility is the degree to which repeated measurements in the test-retest pe-
riod provide similar answers. When testing the reproducibility, a distinction between the 
reliability and agreement is made.15,16 Reliability is determined by the degree to which 
patients can be differentiated from each other, despite the measurement error. This was 
expressed by the intraclass correlation coefficient (ICC) for agreement, scores over 0.70 
are acceptable. Furthermore, the agreement indicates the measurement error which is 
the similarity in scores rated on separate occasions. The limits of agreement (LOA) were 
expressed as the mean change in scores of repeated measurements ±1.96 X standard 
deviation of the changes.16,17 
Criterion validity
The criterion validity, i.e. the extent to which the OAB-q SF questionnaire scores relate 
to a gold standard, is determined with the Pearson’s correlation coefficient (range -1 to 
1) in case of a linear association and when a linear association is not seen, the Spearman 
correlation coefficient. For OAB, a gold standard does not exist, and instead the UDI-6 
and the ICIQ-OAB (Q and BS) served as such. 
Construct validity
Predefined hypotheses about the relation of the OAB-q SF to other instruments were 
tested. The construct validity is considered adequate when at least 75% of the results of 
predefined hypotheses are in accordance.15 The following hypotheses were formulated:
1. The reference group will have lower OAB-q SF symptom bother scores and higher 
OAB-q SF HRQOL scores than the patient group.
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2. Patients with a higher UDI-6 score will have a higher OAB-q SF symptom bother 
score.
3. Patients with a higher ICIQ-OAB Q (questions) score will have a higher OAB-q SF 
symptom bother score. 
4. Patients with a higher ICIQ-OAB BS (bother scale) score will have a lower OAB-q SF 
HRQOL score.
5. Patients with a lower EQ-5D-5L index value and patients with a lower EQ-5D-5L VAS 
will have a lower score on the OAB-q SF HRQOL.
Floor and ceiling effects
Floor and ceiling effects were considered if more than 15% of the respondents would 
achieve the lowest or highest possible score.15 The floor and ceiling effects were cal-
culated for symptom bother and HRQOL scores at baseline in the patient and in the 
reference group. 
Statistical method
A sample size of at least 50 participants was considered adequate for validation of ques-
tionnaires,15 thus we aimed to include a total of 100 patients, 50 in the patient group and 
50 in the reference group. Continuous data are presented as mean, standard deviation 
(SD). The Student’s t-test and Chi-square test for continuous and categorical variables, 
respectively, were used evaluating differences between patient and reference group. 
Statistical analyses were performed using SPSS version 24.0 (IBM Corp., Armonk, NY, 
USA). Statistical significance was defined as P-Value <0.05. 
RESULTS
In total, 103 participants were included in the study. In the patient group 56 patients 
signed an informed consent, of whom 52 patients completed the questionnaires at both 
time points. Four patients did not return the second questionnaire and were therefore 
excluded from the analyses. The reference group consisted of 51 participants who com-
pleted the questionnaires at one time point. Table 1 displays the patient characteristics 
and the baseline scores of the four questionnaires. 
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Table 1. Patient characteristics and baseline outcomes of measurements
Reference group
N = 51
Patient group
N = 52 P-value
Age, yrs 41 (±15) 64 (±13) 0.02a
Gender 0.24b
 Male 14 (28%) 20 (39%) 
 Female 37 (72%) 32 (61%) 
Baseline scores 
 OAB-q SF Symptom bother 12.4 ± 15.4 63.8 ± 21.6 <0.001a 
 OAB-q SF HRQOL 95.9 ± 5.4 50.9 ± 19.1 <0.001a 
 EQ-5D-5L index value 0.881 ± 0.156 0.738 ± 0.212  0.086a 
 EQ-5D-5L VAS 76.1 ± 14.3 71.7 ± 17.3  0.043a 
 UDI-6 8.9 ± 9.1 57.7 ± 20.7 <0.001a 
 ICIQ-OAB Q (questions) 2.3 ± 1.8 10.4 ± 2.9  0.001a 
 ICIQ-OAB BS (bother scales) 3.8 ± 6.3 29.4 ± 8.1   0.037a 
aStudent’s T-test
bChi square test
Content validity
Content validity was confirmed during the face-to-face evaluation of the questionnaire. 
Question 8 of the OAB-q SF HRQOL subscale was discussed, but did not lead to changes 
in the questionnaire. Furthermore, the face-to-face evaluation demonstrated that pa-
tients found the questionnaire understandable, easy to complete and clear.    
Internal consistency
The internal consistency of the questionnaire was tested good for both subscales. 
Cronbach’s Alphas between 0.70 and 0.95 reflect adequate internal consistency. In the 
patient group the OAB-q SF symptom bother subscale the Cronbach’s Alpha scores were 
0.84 and 0.87 for test and retest, respectively. For the OAB-q SF HRQOL subscale the 
Cronbach’s Alpha were 0.88 and 0.91 for test and retest, respectively.   
Reproducibility
In the patient group, the second questionnaire was returned after a mean of 15.8 days 
(SD ± 11). An adequate reliability was confirmed with ICCs higher than 0.70 for the two 
subscales of the OAB-q SF. Table 2 lists the ICCs for agreement and LOA ranges for the 
two subscales of the OAB-q SF. 
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Table 2. The reproducibility is presented in term of the intraclass correlation coefficient (ICC) and the limits 
of agreement (LOA)
Change
(mean ± SD)
ICC
(95%CI) LOAa
OAB-q SF symptom bother -4.23  ± 13.89 0.79 (0.66 – 0.88) -31.45 – 22.99
OAB-q SF HRQOL  2.37 ± 10.83 0.85 (0.76 – 0.91) -18.84 – 23.58 
aCalculated as : y= mean(change) ± 1.96 X standard deviation (change).
Criterion validity
Using Pearson’s correlation coefficient a moderate to very strong correlation was 
detected between the OAB-q SF symptom bother and the UDI-6 and the ICIQ-Q. The 
criterion validity of the OAB-q SF HRQOL was evaluated by calculating the correlation 
with the IQIQ-BS and the EQ-5D-5L index values and VAS. Calculating the correlation with 
the EQ-5D-5L index values, the spearman correlation coefficient was used since no linear 
relationship was found between the OAB-q SF HRQOL and the EQ-5D-5L index value. Cor-
relations demonstrated a weak to strong correlation (See Table 3 for Rho and P-values).  
Table 3. Criterion validity measured using the Pearson’s Correlation coefficient. 
UDI-6 ICIQ-Q ICIQ-BS
EQ-5D-5L index 
value EQ-5D-5L VAS
Test 
OAB-q SF Symptom bother 0.56 (<0.001) 0.84 (<0.001)
OAB-q SF HRQOL -0.67 (<0.001) 0.46 (<0.001)a 0.49 (0.001)
Retest
OAB-q SF Symptom bother 0.72 (<0.001) 0.83 (<0.001)
OAB-q SF HRQOL -0.70 (<0.001) 0.43 (0.002)a 0.33 (0.016)
Values are Rho (P-value)
aSpearman’s correlation coefficient because of nonparametric correlation. 
Construct validity
All predefined hypotheses were confirmed:
1. The reference group did have lower OAB-q SF symptom bother scores and higher 
OAB-q SF HRQOL scores compared to the patient group (Table 1).
2. Patients with a higher UDI-6 score had a higher OAB-q SF symptom bother score 
(Table 3).
3. Patients with a higher ICIQ-OAB Q (questions) score had a higher OAB-q SF symptom 
bother score
4. Patients with a higher ICIQ-OAB BS (bother scale) score had a lower OAB-q SF HRQOL 
score (Table 3).
5. Patients with a lower EQ-5D-5L index value and a lower EQ-5D-5L VAS had a lower 
score on the OAB-q SF HRQOL (Table 3).
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Floor and ceiling effects
In the patient group, no floor or ceiling effects were seen for the two subscales (Table 4). 
In the reference group, floor effects were seen for the symptom bother subscale; 17.6% 
scored the lowest possible score of 0. Moreover, in the HRQOL subscale, a ceiling effect 
was seen, in that 29.4 % of patients scored the highest possible score.   
Table 4. Floor and ceiling effects at baseline. 
References N = 51 Patients N= 52
Floor (%) Ceiling (%) Floor (%) Ceiling (%)
OAB-q SF Symptom bother 9 (17.6 %) 1 (2%) 0 (0%) 4 (7.7%)
OAB-q SF HRQOL 0 (0%) 15 (29.4%) 0 (0%) 0 (0%)
DISCUSSION
The primary aim of this study was to translate and validate the OAB-q SF in the Dutch 
language. The results of this study showed that this Dutch version is valid, reliable and 
consistent. This enables the use of the OAB-q SF in daily practice in the Netherlands. A 
valid tool to measure both symptom bother and health-related quality of life in patients 
with OAB in an easy and fast way.  
The content validity of the questionnaire was confirmed during the face-to-face 
evaluation. Question 8 of the OAB-q SF HRCOL subscale was discussed. One patient 
commented on question 8 in the health-related quality of life subscale: ‘During the past 
4 weeks, how often have your bladder symptoms caused you to have problems with 
your partner or spouse?’. The issue was that response  option ‘not applicable’ was lacking 
for those who had no partner. Because adding this response option would complicate 
the scoring manual, we discussed this problem with the designers of the original ques-
tionnaire.9 In the cohort of Coyne et al, patients either leaved the question blank, and 
it was recorded as missing, or patients answer was ‘None of the time’ given that when it 
is not applicable, it really is none of the time. Therefor the Dutch version did not insert 
‘not applicable’ as answer option, and no changes were made as a result of this discus-
sion.9 Moreover, according to the scoring manual of the OAB-q SF, the total score can be 
adapted to up to 50% of missing items, still creating a score ranging from 0 to 100. 
The significantly different scores in the patient group (higher in symptom bother and 
lower in HRQOL) compared to the reference group, indicated a good discriminative abil-
ity and possible diagnostic value of the OAB-q SF. Comparable to the Cronbach’s alphas 
of the original OAB-q SF (0.82 & 0.91) and the Spanish validation (0.81 & 0.92),9,18 the 
Cronbach’s alphas of the Dutch OAB-q SF were good (0.83 to 0.89), and demonstrated an 
excellent internal consistency. Using the change in scores between the test-retest, the 
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agreement and the limits of agreement were calculated, demonstrating an adequate 
reliability and reproducibility. These results are in accordance with the original OAB-q SF 
study,9 and the Spanish validation study.18 
Concerning the criterion validity, the present study used the UDI-6, the ICIQ-OAB and 
the EQ-5D-5L to correlate with the OAB-q SF because of the absence of a gold standard. 
As expected, the symptom bother subscale showed a strong correlation with the UDI-6 
and the ICIQ-questionnaires for both test and retest. Moreover, the OAB-q SF HRQOL 
subscale showed a strong correlation with the ICIQ-bother scales, but the correlations 
with the EQ-5D-5L index value and EQ-VAS were moderate. The ICIQ-OAB bother scales 
are focused on OAB symptoms and the EQ5D5L is more in general, which might be a 
possible explanation for the moderate compared to strong correlation. The Spanish 
validation study also used the EQ-5D and -VAS and showed comparable, moderate cor-
relations.18 All predefined hypotheses in the present study were confirmed demonstrat-
ing that patients and references are well distinguishable, and therewith showing a good 
construct validity. 
In the patient group, no floor and ceiling effects were detected, which implies that 
although many patients had severe OAB, the questionnaire is still discriminative enough 
to detect worsening or improvement of symptom bother or in HRQOL. In the reference 
group, as expected, a floor effect was found in the symptom bother scale (17.5%), in-
dicating that in the reference group patients had no bother due to bladder problems. 
Moreover, a ceiling effect was seen in the HRQOL scale (29.4%), indicating that in the 
reference group, bladder problems were not severe enough or not present to create a 
decrease in HRQOL. 
The strength of the current study is the use of standardized measurement properties 
as described by Terwee et al. to evaluate the reliability and validity of the OAB-q SF.15 The 
current study did not determine the responsiveness and interpretability due to short 
follow-up, and a lack of therapy changes over time in the study group. This is a limita-
tion of the study, however previous literature on the English OAB-q SF demonstrates 
a good responsiveness and interpretability.9 There was a difference in the mean age 
between the patient and the reference group. The reference group is only used for one 
of the four hypotheses of the construct validity. All the other measurement properties 
are calculated without the use of the reference group, so without influence of this age 
difference. Another limitation of the study is the absence of a gold standard to assess 
the criterion validity. On the other hand, the absence of a gold standard in this highly 
prevalent disease demonstrates the need for a good PRO in OAB. The choice to imple-
ment the OAB-q SF in the ICHOM OAB-set suggests that this questionnaire might be a 
valid PRO for OAB symptoms. 
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Conclusion
In conclusion, this Dutch version of the OAB-q SF showed a good validity and reliability 
according to well established guidelines on measurement properties. The OAB-q SF is a 
suitable instrument for assessing both symptom bother and HRQOL in patients suffer-
ing from OAB. We recommend the use of this measurement tool in both research and 
clinical practice. 
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1 
 
Identificatienummer van de patiënt___________________                        Initialen van de patiënt _____________ 
 
OAB-q SF - korte vragenlijst over de ernst van blaasklachten. 
 
In deze vragenlijst kunt u aangeven hoeveel last u de afgelopen 4 weken heeft gehad van specifieke 
blaasklachten. Kruis het hokje aan dat het beste beschrijft in hoeverre u de afgelopen 4 weken last 
heeft gehad van elke klacht. Er zijn geen goede of foute antwoorden. Let erop dat u alle vragen 
beantwoordt.  
 
Hoeveel last had u gedurende de 
afgelopen 4 weken van 
Helemaal 
niet 
Een klein 
beetje 
Enigszins Nogal Veel Heel veel 
1. Een hinderlijke aandrang om te 
plassen?  
□  □  □  □  □  □  
2. Een plotselinge aandrang om te 
plassen met weinig of geen 
waarschuwing? 
□  □  □  □  □  □  
3. Ongewild verlies van kleine 
hoeveelheden urine? 
□  □  □  □  □  □  
4. ’s Nachts plassen? □  □  □  □  □  □  
5. ’s Nachts wakker worden omdat u 
moest plassen? 
□  □  □  □  □  □  
6. Urineverlies dat samengaat met een 
sterke behoefte om te plassen? 
□  □  □  □  □  □  
 
 
 
 
 
Zie pagina 2.  
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2 
 
Identificatienummer van de patiënt___________________                        Initialen van de patiënt _____________ 
 
Denk bij de volgende vragen aan uw algemene blaasklachten in de afgelopen 4 weken en hoe deze 
klachten uw leven hebben beïnvloed. Beantwoord elke vraag zo goed mogelijk over hoe vaak u zich 
zo voelde. Kruis het hokje aan dat de vraag het beste beantwoordt.  
 
Hoe vaak hebben uw blaasklachten er 
in de afgelopen 4 weken toe geleid…. 
Nooit Heel 
soms 
Soms Vrij 
vaak 
Meestal Altijd 
1. Dat u “vluchtroutes” heeft gepland 
naar toiletten in openbare ruimtes? 
□  □  □  □  □  □  
2. Dat u het gevoel had dat er iets mis 
was met u? 
□  □  □  □  □  □  
3. Dat u geen goede nachtrust kreeg? □  □  □  □  □  □  
4. Dat u gefrustreerd of geïrriteerd 
raakte over hoeveel tijd u op het toilet 
doorbrengt? 
□  □  □  □  □  □  
5. Dat u activiteiten heeft vermeden 
omdat ze ver van een toilet af waren ? 
(bijv. wandelen of hardlopen) 
□  □  □  □  □  □  
6. Dat u ’s nachts wakker werd? □  □  □  □  □  □  
7. Dat u minder lichamelijke activiteiten 
heeft ondernomen? (beweging, 
sporten, etc.) 
□  □  □  □  □  □  
8. Dat u problemen kreeg met uw 
partner of echtgenoot/echtgenote? □  □  □  □  □  □  
9. Dat u zich tijdens het reizen met 
anderen ongemakkelijk voelde omdat u 
onderweg naar het toilet moest? 
□  □  □  □  □  □  
10. Dat het invloed had op uw relatie 
met familie en vrienden? □  □  □  □  □  □  
11. Dat u minder slaap kreeg dan u 
nodig had? □  □  □  □  □  □  
12. Dat u in verlegenheid werd 
gebracht? □  □  □  □  □  □  
13. Dat u bij aankomst op een 
onbekende plek meteen zocht naar  het 
dichtstbijzijnde toilet?  
□  □  □  □  □  □  
 


2 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
CHAPTER 7
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ABSTRACT
Objectives: To evaluate the long-term results after the construction of a Continent 
Catheterizable Urinary Conduit (CCUC) in adults. 
Methods: We retrospectively reviewed the charts of 41 adults from two tertiary centers 
who received a CCUC. The demographics, underlying diseases, indications for a CCUC 
and outcomes such as the reoperation rate and the occurrence of complications were 
extracted. The patient reported outcome was measured with the Patient Global Impres-
sion of Improvement (PGI-I) scale and four additional questions about continence, leak-
age and stomal problems.   
Results: Twenty-nine patients were women. The median age at surgery was 32 years 
with a median follow-up of 52 months. Twenty-six patients had a neurogenic bladder. 
The reoperation rate was 48.8% with a median of 10.5 months after constructing the 
CCUC. Superficial stomal stenosis was the most common registered complication (20 
times) and stoma revision was the most often performed reoperation (12 times). Twenty-
four patients completed the PGI-I; the mean improvement rating was 2 (= much better). 
Conclusion:  The construction of a CCUC in adults is associated with a high complica-
tion and reoperation rate. The high reoperation rate is in accordance with the sparse 
literature. Despite this, patients reported “much better” on the PGI-I. 
Keywords: Urinary diversion, Lower Urinary Tract Symptoms, Adults, Complications.
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INTRODUCTION
Many patients with neurogenic or non-neurogenic lower urinary tract dysfunction are 
dependent on either clean intermittent catheterization (CIC) or an indwelling catheter 
for bladder emptying. Despite good instructions and feasible equipment, both ap-
proaches may give rise to problems such as urinary tract infection, pain and bleeding.1-3 
CIC requires a good dexterity, which may be challenging for people with spinal cord 
injury, especially those patient that are wheelchair bound. If management with CIC or 
an indwelling catheter affects a patient’s quality of life too much, the alternative is to 
construct a continent catheterizable urinary channel (CCUC).4 Mitrofanoff appendi-
covesicostomy and the Monti ileovesicostomy are the most often used catheterizable 
channels.5-7 These procedures have been used in children and adolescents for more than 
three decades. Recently, our group showed that an appendicovesicostomy is an effec-
tive and durable solution for children when CIC is not feasible.8 Little is known about 
the feasibility and risk factors for complications of CCUCs in adults. Publications so far 
show a wide range of complication rates and most cohorts included only patients with 
a neurogenic bladder dysfunction.7,9-11
The aim of this study was to evaluate the long-term results of CCUCs applied in adults 
and to identify possible risk factors for complications.
MATERIALS AND METHODS
The medical charts of 41 consecutive adults who had received a CCUC were retrospec-
tively reviewed. Surgeries had been performed by three different experienced urologists, 
between November 1998 and November 2016 at the Erasmus University Medical Center, 
Rotterdam and at the University Medical Center Groningen, Groningen. The procedures 
used were those described by Mitrofanoff or Monti.5,6 A Stoma was constructed either in 
the umbilicus with a V-shaped skin flap or in the right lower abdomen. A catheter was 
placed in the constructed stoma. Three to six weeks later the catheter was removed and 
the patient started with CIC. Follow-up was initially every 3 to 6 months, but the time 
interval was extended up to a year if bladder function remained stable and catheteriza-
tion proceeded without problems. 
After obtaining approval by the local ethics committee (MEC-2017-354), all patients who 
were still using the channel by the end of December 2017 were sent a 5-item questionnaire. 
The first question was the global impression of improvement (PGI-I instrument). 1) The 
PGI-I is a single question to rate the urinary tract condition now, as compared to before 
beginning treatment (construction of the CCUC) on a scale from 1: Very much better, to 7: 
Very much worse. The other questions were addressing 2) continence of the stoma (com-
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pletely dry/some leakage, 1 pad is enough/ leakage with need for a stomal bag/stoma is 
completely incontinent/catheter in stoma), 3) urethral leakage (did you have any urethral 
incontinence the last two weeks? Yes/no), 4) difficulty with catheterization (always easy/
most of the time easy, sometimes not easy or painful/ always problematic or painfull), 
and 5) willingness to recommend this procedure to others with a comparable condition.
Demographic data extracted included patients’ sex, age, body mass index (BMI) at time 
of surgery, length of hospital stay, underlying disease and the indication for a CCUC. Num-
ber of reoperations and the occurrence of complications served as outcome measures. 
Stenosis was sub-divided in to cutaneous/fascial stenosis (superficial stenosis) and 
stenosis at conduit-bladder level (deep stenosis), stenosis was considered as a complica-
tion if a dilatation or a reoperation was needed, and the stenosis could not be resolved by 
minimally invasive therapies like ACE-stoppers or night-time catheters. Stomal or urethral 
urinary incontinence (UI) was considered a complication if reoperation was considered or 
patient could not properly absorb the leakage with incontinence material. Stomal pain 
during CIC was considered a complication if the patient had visited the emergency room 
or the outpatient clinic because of problems with CIC caused by pain or had been hos-
pitalized for this reason. Urosepsis was considered as a complication when the patient 
was hospitalized for this reason. Stoma related reoperations were either stoma revisions 
(superficially), conduit revisions ( including re-implantation of the conduit into the blad-
der), channel replacement (Mitrofanoff-channel to monti-channel, or monti-channel 
to a new monti channel), closing of the channel, using bulking agent at stoma level or 
augmentations. The use of a bulking agent in the urethra and dilatation of the stoma 
under general anesthesia were also registered but not as a stoma related reoperation. 
Statistical analyses were performed with the statistical package SPSS statistics 24. Non-
normally distributed variables are presented as median (interquartile range). Tests for 
normality were performed using the Shapiro-Wilk test. Non-parametric and Chi-square 
tests were performed to analyze risk factors (age and BMI) for reoperation. A P-value of 
< 0.05 was considered as statistically significant. 
RESULTS
Table 1 shows patient demographics and diagnoses. The median follow-up was 52 
months, with an interquartile range (IQR) from 19 to 120 months. The underlying diagnosis 
was neurogenic bladder in 26 patients (63%) and non-neurogenic bladder in 15 patients 
(37%). Concomitant surgery was performed in 24 patients; ileocystoplasty was the most 
common performed concomitant surgery (n=16). Bladder outlet procedures like bladder 
neck surgery or a bladder neck sling were performed in 6 patients. Two patients received 
onabotulinumtoxinA injections per-operatively. The stoma was placed umbilically in 35 
(85%) cases. In 6 (15%) cases the stoma was placed in the right lower abdomen
Long-term results of continent catheterizable urinary channels 137
7
 
Table 1. Patient demographics. 
Patients N = 41
Sex  (%) Male / female 12 (29) / 29 (71)
Age at surgery in years, median (IQR) 32 (23 – 49)
BMI, median (IQR), 14 missing 25 (22.6 – 31.4) 
Length of follow-up in months, median (IQR) 52 (19 – 120)
Bladder capacity pre-surgery in ml, median (IQR), 8 missing 400 (250 – 500)
Hospital stay days after surgery (range), 1 missing 10 (6 – 14)
Diagnosis/underlying diagnosis
Neurogenic bladder (%) 26 (63)
Meningomyelocele 11 (27)
Spinal cord injury/cerebral contusion 7 (17)
Multiple sclerosis/other muscle disease 3 (7)
Polyneuropathy 2 (5)
Cerebral palsy 2 (5)
Pelvic injury 1 (2)
Non-neurogenic bladder (%) 15 (37)
Idiopathic bladder retention 4 (9)
Severe urethral strictures 3 (7) 
Bladder-pain syndrome 1 (2)
Ehlers-Danlos syndrome 1 (2)
Prune-Belly syndrome 1 (2)
Other 5 (12)
Indication construction CCUC
Neurogenic bladder (%) 26 (63)
Urethral leakage despite urethral CIC 7 (17)
Reduced dexterity 6 (15)
CIC while in a wheelchair 4 (10)
Urethral stricture’s/fistula’s by CIC 4 (10)
Pain during CIC 2 (5)
Other 3 (7)
Non-neurogenic bladder (%) 15 (37)
Pain during CIC 5 (13)
Reduced dexterity/hand/shoulder  4 (10)
Urethral strictures 3 (7)
CIC while in a wheelchair 1 (3)
Other 2 (5)
Type of surgery  (%)
Mitrofanoff 24 (59)
Monti-channel 17 ( 41)
Abbreviations: IQR; interquartile range, CIC; clean intermittent catetherization.
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Patients with neurogenic bladder  (n=26)
Underlying diagnoses and indications are shown in table 1. One patient showed no blad-
der activity during urodynamic evaluation after severe traumatic pelvic injury. 
Patients with non-neurogenic bladder (n=15)
Underlying diagnoses and indications are shown in table 1. Furthermore, one patient 
had severe dysfunctional voiding with residual micturition and progressive kidney 
insufficiency. One patient had a conversion disorder, three other patients had a hypo-
contractile bladder.  
Complications and reoperations 
The overall reoperation rate was 48.8% (n=20) with a median of 10.5 months (IQR 4.5 
– 30.8) after constructing the CCUC. This concerned 13 patients (50%) with neurogenic 
bladder and 6 patients (40%) with non-neurogenic bladder. There was no difference in 
the amount complications between the two centers. 
From all complications superficial stenosis was by far the most common registered 
complication (20 times), followed by stomal incontinence (10 times). Stenosis at conduit-
bladder lever occurred 4 times and stomal pain was considered a complication 3 times. 
Urosepsis occurred 3 times and urethral incontinence occurred twice. Stoma revision was 
the most performed reoperation (12 times) followed by conduit replacement (6 times). 
Complications and reoperations of patients with a neurogenic bladder are detailed in 
table 2, complications and reoperations of patients with a non-neurogenic bladder are 
detailed in table 3. Complications and reoperations could occur more than once in a 
patient.  
Factors of influence
Factors potentially influencing the reoperation rate were analyzed. The probability of 
reoperation was significantly higher for patients above the age of 32 years compared 
with younger patients (Chi-square test p=0.043). 
For BMI above or under the median BMI of 25, the Chi-square test was not statistically 
significant (p=0.431). BMI was missing in 14 cases.  
Questionnaire
The questionnaire was sent to 32 of the 41 patients. Reasons not sending the question-
naire to 9 patients were: the stoma had already surgically been closed (n=4), permanent 
catheter in the stoma (n=2) and death, unrelated to the CCUC (n=3). The response rate 
was 24/32 (75%) of which 5 were males, the rest were females. The median PGI-I rating 
was 2 (much better) and all but two of the patients who had returned the questionnaire 
(22/24) would recommend this surgery to others in a comparable situation. See table 4 
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for other questionnaire results. Of the 10 patients who answered “some leakage from 
the stoma, but 1 pad is enough”, 4 had undergone a concomitant ileocystoplasty during 
construction of the CCUC. Of the 9 patients with some urethral incontinence, 5 patients 
(all female)  had undergone a concomitant ileocystoplasty. 
Table 4. Questionnaire results. Abbreviations: PGI-I; patient global impression of improvement.
 N = 24
PGI-I
 1. Very much better  9 
 2. Much better  8 
 3. A little better  3 
 4. No change  1 
 5. A little worse  2 
 6. Much worse  1 
 7. Very much worse  0 
Continence stoma
 Dry 11 
 Some leakage, pad enough 10 
 Incontinent/catheter/other 1/1/1 
Continence urethra
 Yes 9 
 No 15 
Catheterization stoma*
 Always easy, no pain 9 
 Easy, sometimes problematic 10 
 Most of the time problematic 2 
 Always problematic 2 
Would you advise this surgery to others?
 Yes 22 
 No 2 
*Catheterization stoma: 1 missing
DISCUSSION 
Twelve of 41 patients had remained entirely complication-free after the construction of 
a CCUC for different indications. The other 29 patients presented with superficial stomal 
stenosis, stomal or urethral UI, stenosis at conduit-bladder level, pain or urosepsis and 
20 of them needed at least one reoperation. Furthermore, the perceived improvement 
was ‘much better’ and 22 of 24 patients would recommend this surgery to others. Ef-
fective patient counseling before constructing a CCUC is important, as shared decision 
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making is only possible when the patient is aware of the possible complications and the 
probability of reoperation. 
The applicability of a CCUC in adult patients with lower urinary tract dysfunction re-
mains questionable. An important consideration is the lack of other options when qual-
ity of life is affected by painful CIC, difficulty in performing CIC, urinary tract infections 
or problems with indwelling catheters. An alternative might be an incontinent urinary 
diversion (Ileum conduit), but this type of surgery is more invasive and also known for 
its complications. Most patients would prefer a continent stoma.12
Table 5. Overview of the published literature.
Author Year
Patients 
N/NN Follow-up Age Continence Stenosis
Re-
operation
Current study 2019 26/15 52 M (19–120) 32 Y (23–49) 88% 46% 49%
Perrouin-Verbe et al. 2016 29/0 66 M (50-80) 35 Y (26-46) 100% 6% 24%
Rey et al. 2013 11/4 22 M ( 9-33) 32 Y (22–65) - - 20%
Van der Aa et al. 2009 12/23 62 M (6–117) 44 Y (21–80) 75% 29% 54%
Sahadevan et al. 2008 7/22 10.5 Y (0.4–16) 48 Y (18–79) 89% 57% 49%
Touma et al. 2007 12/0 2.8 Y (0.25–5.8) 27 (14–50) - - -
Karsenty et al. 2007 12/0 44 M (20–56) 42 Y (18–63) 100% - 0%
N = neurogenic bladder, NN = non-neurogenic bladder, M = months, Y = year.
The reoperation rate of 48.8% we found falls within the range reported in the sparse 
literature (detailed in table 5).10,13-17 Studies on predicting factors for complications have 
shown contradictory results. In a study by De Ganck et al. in 53 patients (mean age 19 
years, SD 13), multiple regression analysis showed no association between the complica-
tion/follow-up ratio and age.15 In contrast, Sahadevan and colleagues described a sig-
nificantly increased incidence of stomal complications in 29 patients aged > 50 years.14 
A recurrent point of discussion is the heterogeneity of the studied populations, making 
a balanced comparison challenging.11 Together with low numbers of patients, statistical 
analysis to find predicting factors for complications or reoperation is difficult. We found 
a significantly increased risk on reoperations for patients above the age of 32 at the 
time of surgery. This finding should be interpreted with caution, as duration of follow-
up may be a confounding factor. A high BMI has not yet been identified as significant 
risk factor for stomal complications in patients with a CCUC, which could be due to the 
small patient samples studied. However BMI is reported as risk factor for complications 
in many other types of stoma, for example colorectal stoma.18 Moreover, in patients 
with a myelomeningocele or other spinal cord diseases, the BMI might not be a good 
predictive parameter for the amount of abdominal fat, because BMI is not taking the 
underdeveloped muscles in the legs of these patients in to account. In essence, all this 
information could be helpful for the urologist and the patient to decide on constructing 
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a CCUC or not. Nine patients were, at the time of data collection, not using their CCUC 
anymore. Hopefully,  this study contributes to make a better patient selection. 
Besides the patient-related risk factors, other factors might influence the risk of 
complications, such as the quality of pre- and post-operative care. This quality can be 
enhanced by the availability of a specialized nursing team creating optimization of 
instructions and practice of self-catheterization.  
One of the strengths of this study is the use of a questionnaire, which provided more 
insight in patients’ opinions, which appeared positive despite the high reoperation rate. 
Obvious limitations include the limited patient numbers and the retrospective character 
of the collected data. Furthermore, we did not send the questionnaire to the patients 
who did no longer use the CCUC and had received new treatments. Therefore, the 
questionnaire results on the use of the CCUC may have been biased to some extent, 
and these results may be questioned. Nine out of 24 patients stated that they had some 
urethral leakage during the past two weeks. Five of these had undergone a concomitant 
ileocystoplasty, all females. We cannot differentiate between a preexistent stress urinary 
incontinence or an incontinence due to a low capacity based on this question. Bladder 
capacity was measured using urodynamics in every patient before the construction of a 
CCUC, and an ileocystoplasty was constructed if the bladder capacity was low.  
In conclusion, the construction of a continent catheterizable urinary channel in adults 
comes with a relatively high number of complications, no risk factors could be identified 
yet. In the context of shared decision making, both the urologist and the patient should 
carefully consider the risk of failure of the constructed CCUC, the reported results of the 
questionnaire and the paucity of other options. Prospective studies with larger cohorts 
will be needed to identify predicting factors for complications.  
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In the field of functional urology, the availability of outcome parameters is limited. At 
present, the main outcomes are related to the subjective symptom perception of the pa-
tient. Due to the lack of outcome parameters,  progress in scientific and clinical research 
in the field of functional urology might be obstructed. In this thesis, we attempted to 
expand the knowledge on (patho)physiology, identifying objective outcome measure-
ments, improving subjective outcome measurements in the form of patient reported 
outcome measurements (PROMS), and contribute to the development of prediction 
models towards personalized care in functional urology.
DYNAMIC BRAIN IMAGING: A FUTURE DIAGNOSTIC TOOL IN FUNCTIONAL 
UROLOGY?
In the first part of this thesis we focused on the innervation of the lower urinary tract 
(LUT) and investigated the possible use of dynamic brain imaging as objective outcome 
measurement in clinical practice.  
1. Do we know which brain areas are of interest when investigating the LUT?
The evolution of dynamic brain imaging generated an increase in knowledge on the 
innervation of the LUT.1-5 Still, there is no consensus on which brain areas are involved 
in central LUT control.6 Several properties of the acquisition and processing of dynamic 
brain imaging, make it hard to summarize the available data. Examples of these proper-
ties are the heterogeneous characters of the tasks performed in the MRI scanner (for 
instance different ways of bladder filling), the heterogeneous scan paradigms (for 
instance length and repetition of tasks), mixed genders, mixed patient populations as 
well as differences in used techniques (PET/1.5T fMRI/3T fMRI). A coordinate-based meta-
analysis can be used to create a comprehensive overview of the relevant brain areas. A 
widely accepted method for coordinate-based meta-analysis is the activation likelihood 
estimation (ALE) which uses the inserted coordinates as a spatial probability distribu-
tion. In chapter 2, an ALE analysis using all published data on this topic indicated which 
brain areas are involved in the motor control of the LUT, divided into pelvic floor muscle 
contraction and micturition. The shortage of available data necessitated us to perform 
the ALE analysis with a lenient threshold; the results should thus be interpreted with 
caution. The results of this chapter are, to the best of our knowledge, the first results on 
motor innervation of the LUT investigated in more than 100 patients.  
The brain areas that showed to be involved are in accordance with the findings of other 
relevant systematic reviews (without meta-analysis), although most literature focused 
on bladder control and not on pelvic floor muscle control.6-9 We have demonstrated that 
two different motor tasks of the LUT, are innervated by distinct brain areas. 
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A previous study used ALE analysis in 181 patients to demonstrate which brain 
areas are involved during bladder filling, which is the main sensory task of the LUT.10 
Bladder filling has often been studied, whereas the somatosensory representation of 
the genitals has rarely been investigated.11-14 Data seem not yet sufficient to perform 
a meta-analysis on the somatosensory representation of the external genitalia. The 7T 
fMRI study presented in chapter 3 showed which brain areas are involved in pelvic floor 
muscle contractions in healthy individuals. The 7T fMRI study presented in chapter 4 
demonstrated which brain areas are involved in the individual processing of sensory 
information of male genitals in healthy individuals. The findings of chapters 2, 3 & 4, 
increased the knowledge on the involved brain areas in the central motor and sensory 
control of the LUT. This basic knowledge about the central control of the LUT is essential 
for the use of fMRI in individual patients in clinical practice.
2. Are the activity patterns divergent between patients and healthy subjects?
The further applicability of dynamic brain imaging to study the control of the LUT 
depends on clinical validation of the differences observed in outcomes between differ-
ent populations, i.e. healthy persons versus patients and between patients before and 
after therapy. Research has demonstrated on group level that the results of dynamic 
brain imaging are different between patients and healthy subjects, and before and after 
therapy. Several brain areas, such as the supplementary motor area, the cingulate gyrus 
and the prefrontal cortex, have been described to be of interest when studying these 
differences.15-20 At present, it is still unclear whether the differences between patients 
and healthy individuals and before and after therapy are detectable on individual level. 
3. Is this ‘tool’ eligible for studying the LUT in individuals? 
Single subject results obtained with the use of ultra-high field imaging regarding more 
basic tasks (e.g. digit somatotopy) have been found complementary to group results.21, 22 
Results on individual level for the LUT are scarce, however, which is at least partly related 
to the suspected inter-individual differences caused by the affective involvement in 
these tasks.23 In the studies presented in chapters 3 & 4, activity patterns of individuals 
were analyzed using 7T fMRI to investigate whether in relation to the motor and sensory 
innervation of the LUT these patterns are comparable to group results. Both studies 
demonstrated that 7T fMRI is a feasible technique to study LUT whole-brain activity pat-
terns at single-subject level. 
4. Do we need ultra-high field imaging? 
In previous studies using 1.5T and 3T fMRI, demonstrating individual results was uncom-
mon as these results would not have a spatial acuity that allows for interpretation of 
individual results.23 At 7T, signal-to-noise ratios and blood-oxygenation-level-dependent 
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signals have higher sensitivity, thereby increasing the spatial resolution.24 Studies 
comparing results obtained at 3T with results obtained at 7T demonstrate relevant dif-
ferences.22,25 These studies are suggesting that the increase in resolution at 7T allows 
for interpretation of individual results. The above-mentioned arguments demonstrate 
ultra-high field (7T) imaging should be preferred for implementation of fMRI in clinical 
practice.    
5. Is 7T fMRI available in clinical practice in the future?
The main drawbacks of 7T, compared to 1.5/3T, are the susceptibility for motion artefacts 
and some specific technical problems. For example, in 4 out of 17 patients included in 
chapters 3 & 4, the data could not be used due to motion artefacts. Furthermore, at 
present, data processing methods are relatively time consuming. These issues might 
diminish as the technique of high field imaging is evolving. Moreover, the safety of 7T in 
patients with implantable devices still has to be demonstrated.26 Lastly, 7T MRI scanners 
are limitedly accessible and their use as diagnostic in clinical practice is therefore still 
very rare. In the Netherlands, three 7T scanners are available and these are mainly used 
for scientific purposes. The costs of such investment in hospitals are considerable, which 
might impede the implementation of 7T in clinical practice.     
In conclusion, we further defined the involved brain areas in the central control of the 
LUT and the present results suggests that ultra-high field fMRI is an eligible tool in 
individuals. Thus, 7T fMRI might be suitable as a future ‘diagnostic tool’ in the field of 
functional urology. Some important issues need to be addressed before this technique 
can be implemented in clinical practice. First, gathering more fMRI data on both healthy 
individuals and patients is necessary to define the pathophysiology of diseases in the 
field of functional urology and to specifically delineate the differences in the results of 
fMRI between patients and healthy individuals. Standardized protocols for, i.e. bladder 
filling tasks, pelvic floor muscle contraction tasks and micturition tasks appear relevant 
to decrease the heterogeneity between studies. Furthermore, this high-field imaging 
technique is time consuming and limitedly accessible, issues that might diminish with 
the evolution of this technique.
IMPROVING TRADITIONAL AND PATIENT REPORTED OUTCOME 
MEASUREMENTS IN FUNCTIONAL UROLOGY
A future perspective is the creation of a prediction model that includes patient char-
acteristics and (objective and subjective) outcomes to personalize the management of 
diseases in the field of functional urology. Such model might increase the success rates 
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of therapies. Furthermore, it might save time and healthcare costs and could reduce 
symptom bother and needless side effects of insufficient therapies.27 To realize such a 
personalized management tool, the amount of data on patient characteristics, diseases, 
outcomes, patient reported outcome measurements (PROMS) and risk for complications 
needs to increase and the quality of the data needs to improve. In the second part of this 
thesis we aimed to evaluate and improve traditional outcomes and PROMS. 
Improvement of the use of objective outcomes in functional urology 
An objective outcome in the field functional urology is a urodynamic study. It measures 
several parameters in context of bladder function during both the filling and voiding 
phase, like bladder capacity, compliance and contractility.28 Previous studies have inves-
tigated whether urodynamic parameters in patients with overactive bladder are predic-
tive for the chance of success upon sacral neuromodulation (SNM). A significant relation 
between urodynamic parameters and outcomes of the test phase for SNM has not been 
demonstrated.29,30 Nevertheless, significant changes on urodynamic parameters were 
seen during SNM therapy > 6 months.31,32 The objective of the study in chapter 5 was 
to demonstrate whether this effect on urodynamic parameters was visible after acute 
SNM. We demonstrated that there was no immediate effect of SNM on standard urody-
namic parameters. In contrast, Dombek et al. recently demonstrated an acute effect of 
transcutaneous electrical nerve stimulation on urodynamic parameters in children with 
a neurogenic bladder.33 The influence of the differences in age, bladder disorders, type 
of neuromodulation and underlying neurological disorder between Dombek et al. and 
our study chapter 5, is unclear. Apart from predicting success rates of SNM using uro-
dynamic parameters, another argument to study acute effects of SNM is to explore the 
feasibility of a closed-loop feedback system, in which SNM is activated when the bladder 
pressure increases in the context of detrusor overactivity.34,35 The effect of intermittent 
SNM seems comparable to that of continuous SNM, which might imply the appropriate-
ness of such closed-loop feedback system.36 
Predicting outcomes of therapies in patients with overactive bladder has not been 
very successful yet, causing that often multiple therapies are explored to find the most 
efficient one. Chapter 5 is in accordance with other literature which mentions that objec-
tive parameters do not seem appropriate as prognostic measurements for the success 
of SNM treatment in overactive bladder.29,30,37 The question raises whether dynamic brain 
imaging plays a future role as objective parameter in the prediction of responses to 
therapy. In this context, acute and chronic effects of SNM on activation patterns in brain 
areas have been demonstrated in patients.38 For near future predictive models, the use 
of PROMS might be suitable, since the outcomes of objective and subjective measure-
ments still seem to be very divergent in patients. The consistent use of validated PROMS 
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needs to be stimulated in order to increase the amount of high quality data towards 
such prediction model in functional urology. 
Improvement of patient reported outcome measurements in functional 
urology
Physicians are trained proactively in including patients perspectives and to perform 
shared-decision making in order to maintain or improve quality of life (QoL) whilst 
improving survival. This has encouraged the development of PROMS. Important steps 
in implementation of questionnaires in health care are their translation and validation 
in the language and population in which they are used. In chapter 6, such translation 
and validation was executed, to make the “OAB-q SF” questionnaire usable in the Nether-
lands. For different diseases in functional urology, different PROMS have been translated 
and validated so far.39-42 Health care organizations, such as the International Consortium 
for Health Outcome Measurements (ICHOM) have created ‘core-sets’ of questionnaires to 
use within a specific subspecialty or disease category and suggest worldwide consensus 
and use of these sets.43 The use of these PROMS-sets has to be encouraged as a means 
to gather more data, which in turn would facilitate developing a good prediction model. 
This ICHOM initiative creates the possibility to compare results of therapy for different 
types of patients. The OAB-q SF questionnaire, is to be used in the work-up for patients 
with overactive bladder.43 More knowledge on predicted outcomes might not only 
improve the success rates of conservative treatments but also achieve better patient 
selection for successful invasive treatments.
Improvement of patient selection for invasive treatments in functional urology
In the study presented in chapter 7, we investigated the outcomes of the construction 
of a continent catheterizable urinary channel in patients with bladder dysfunctions. In 
this invasive surgical procedure a urinary stoma is constructed on the anterior abdomi-
nal wall using a part of the bowel, and by catheterization of this stoma, the bladder can 
be emptied. The decision to undergo such invasive treatment with major impact on the 
patient’s body image for a non-lethal disease is complex as the aim of the treatment is 
improvement of the QoL. The possible risks and benefits should therefore be weighted 
carefully.44,45 A challenge in the decision making, is the lack of predictive factors for the 
risk of complications, and in case of complications a possible decrease in the QoL.  There-
for the identification of these risk factors is important and could improve the patient 
selection for this treatment.46,47 The study quality of chapter 7 was limited, however, 
by the retrospective design. Since improvement in QoL is the aim of this therapy, this 
subjective outcome parameter should be reported pre- and postoperatively. Research 
in this patient category is hampered, by the limited number of patients, the hetero-
geneous disease presentation, and the differences between the various interventions 
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applied. A worldwide registry, with extensive and validated use of PROMS before and 
after surgery, including all patient characteristics, would possibly identify pre-operative 
risk factors for complications and might improve the patient selection for this treatment 
and other invasive treatments within functional urology. Within the near future, it might 
be optimistic to realize such registry. Therefore, until such implementation, all centers 
need to register PROMS and outcomes diligently to at least improve the quality of the 
available data.
EPILOGUE AND SUGGESTIONS FOR FUTURE RESEARCH
This thesis investigated the brain areas involved in central control of the LUT and thereby 
increased the knowledge on (patho-)physiology of bladder dysfunctions. Furthermore, 
with using 7T-fMRI we identified a possible objective outcome measurement within the 
field of functional urology. We have made progress in profound knowledge on both 
objective (urodynamic studies) and subjective (OAB-q SF questionnaire) outcomes 
measurements, and investigated the prognostic factors for complications on invasive 
surgery within functional urology. Functional urology is a challenging sub-specialty in 
which the use of a prudent combination of objective and subjective outcome measures 
is necessary to provide optimal care. There is room for improvement of these outcome 
measures, the possibilities of which we explored. However, still many questions remain. 
Therefore, suggestions for future research are divergent, ranging from basic science to 
postulate the pathophysiology of functional bladder disorders to clinical research yield-
ing more data on outcome measures. 
- In dynamic brain imaging, more individually assessable data needs to be generated 
on both healthy subjects and bladder dysfunction patients, with protocolled scan, 
task and analytic paradigms. This approach will increase the knowledge on the 
pathophysiology, and possibly reveal therapeutic targets. 
-  The search for alternative techniques to study activity patterns and therapeutic 
targets, that are easier accessible and less prone to artefacts needs to continue. 
Candidate techniques  are  near-infrared spectroscopy and transcranial magnetic 
stimulation.48 
- In clinical practice, the use of standardized PROMS-sets needs to be encouraged, 
which will greatly contribute to developing of a good prediction model, thereby 
enlarging the chance of successful treatment in patients with functional bladder 
disorders. 
- A registry needs to be developed for patients needing invasive treatments for func-
tional bladder problems. This registry will, apart from the stimulation for the use of 
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PROMS before and after treatment, possibly identify risk factor for complications and 
therefor improve patient selection.  
Without a long-term goal, we would have nothing to aim for: What if we could combine 
the results of dynamic brain imaging with PROMS, in a future prediction model for functional 
bladder disorders including pain, which is realized by using a worldwide registry of patients 
with functional bladder disorders, therefore provide optimal personalized care, with high 
long-term success rates on therapies, and low chances on complications?
158 Chapter 8
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SUMMARY
The field of functional urology includes functional disorders of the lower urinary tract 
(LUT), consisting of the bladder, its sphincters and the pelvic floor muscles. The physiol-
ogy of the LUT with its peripheral and central innervation is explained in introductory 
chapter 1 of this thesis. Furthermore, different disorders of the LUT with their symptoms 
and the diagnostics used are summarized. Relevant diagnostics include objective and 
subjective outcome measurements. Objective outcomes are measurements such as the 
number of voids per day or the post void residual. Subjective outcome measurements, 
usually in the form of a questionnaire, are designed to report patient’s perceptions, such 
as the symptom bother and health-related quality of life. Additionally, in this chapter 
the working mechanism of dynamic brain imaging is explained, in particular the work-
ing mechanism of functional MRI (fMRI). Lastly, the available therapies for the subset of 
disorders are discussed, ranging from conservative, pharmacological to invasive treat-
ments. It is emphasized, despite an increasing quality and amount of evidence in this 
field, there is a lack of knowledge on pathophysiology, diagnostics and therapies. This 
thesis aimed to investigate potential diagnostic tools in the field of functional urology 
and to improve objective and subjective outcome measurements. 
The first part of this thesis reviews the present knowledge on brain control of the LUT 
and describes the usage of high-resolution 7T fMRI as a possible diagnostic tool in the 
field of functional urology. The brain areas involved in the innervation of the LUT were 
further defined, and we concluded that ultra-high field fMRI is a suitable technique to 
investigate brain areas involved in LUT control in individuals. 
Chapter 2 describes a systematic review and meta-analysis which aimed to gener-
ate an overview of the brain areas involved in motor control of the LUT. Following a 
systematic search of the literature, 5718 publications were screened on relevance, of 
which in total 19 studies were included. Of these 19 studies, eleven investigated pelvic 
floor muscle contractions (PFMC) and eight micturition. All given coordinates of active 
clusters following the execution of these tasks were extracted by two authors inde-
pendently. Using these coordinates, a coordinate-based meta-analysis was performed 
in the form of an activation likelihood estimation (ALE) analysis. ALE analysis uses the 
included coordinates as a spatial probability distribution to create a ‘mean distribution’. 
To investigate PFMC, a total of 113 coordinates were entered, derived from 170 subjects. 
The results showed clusters in the primary motor cortex, supplementary motor areas, 
cingulate gyrus, frontal gyrus, thalamus, supramarginal gyrus and the cerebellum. In the 
micturition ALE analysis, we entered 98 coordinates of a total of 107 subjects. It revealed 
clusters in the pontine micturition center, periaqueductal grey, cingulate gyrus, frontal 
gyrus, insula and ventral pons. When comparing the results of PFMC to those of micturi-
tion, we found that these two motor tasks of the LUT are innervated by distinct brain 
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areas, only showing overlap in the mid cingulate gyrus and the left thalamus. An im-
portant consideration when interpreting the results of chapter 2 is the limited amount 
of data available for the ALE analysis. Moreover, it shows that more data is necessary on 
this topic to learn more about the physiology and subsequently the pathophysiology of 
diseases including motor control of the LUT. In this thesis the ALE analysis is used for the 
first time to investigate PFMC and the knowledge involved brain areas for specific tasks 
is increased. 
To improve and enlarge data available on this topic, next to chapter 2, chapter 3 and 
chapter 4 report on our findings of 7T fMRI studies, during motor tasks and sensory 
tasks. We used group and individual analysis to investigate the brain areas involved in 
these tasks. The main goal of these studies was to investigate the applicability of 7T fMRI 
to study individual activity patterns involved in LUT control in the whole brain. For 7T 
fMRI to be suitable as potential diagnostic tool, significant results need to be available 
in individual patients.  
Both chapters included 17 subjects. Data of four subjects could not be used due to 
motion artefacts. In chapter 3, subjects performed PFMC and tongue movements in the 
7T MRI scanner. The latter task was chosen as mid-line control task. In chapter 4, tactile 
stimulation of the penile shaft was studied, with tactile stimulation of the feet served as 
control task. Data of both studies revealed that single subject results in the whole brain, 
were complementary to group results. An important finding of chapter 4 is the location 
of activation on the primary sensory cortex (S1) during tactile stimulation of the penile 
shaft. The study showed that the genitalia are represented in the hip region in S1 and not 
below the feet, as stated in earlier publications with group analysis in lower resolution 
MRI scanners. 
The studies presented in the second part of this thesis aimed to investigate and im-
prove both objective and subjective outcome measurements within functional urology. 
When a patient with overactive bladder does not respond to conservative or phar-
macological therapies, a minimally invasive therapy known as sacral neuromodulation 
(SNM) can be considered. Before the lead and neuromodulator are implanted, SNM first 
need to be tested in a test-phase. The study presented in chapter 5 investigated whether 
urodynamic parameters show an acute effect on SNM in patients with overactive blad-
der (OAB). There was a threefold rationale for this study. First, to increase knowledge on 
the working mechanism of SNM; second, to evaluate whether urodynamic parameters 
could be used instead of or complementary to this test-phase; and third, to investigate 
the usefulness of a ‘closed-loop feedback system’ in which SNM automatically activates 
when the bladder pressure increases. We found no acute effect of SNM on urodynamic 
parameters. This observation suggests that SNM primarily works via sensory pathways 
and not directly via motor pathways. This does not rule out the possible effects of a 
closed-loop feedback system, as explained in the discussion of chapter 5. 
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In functional urology, results of objective outcomes can diverge much from the results 
of subjective outcomes in the same patient. Functional disorders can cause a wide range 
of symptoms, of which the influence on quality of life can differ per person. Therefore, 
apart from objective measurements like bladder diaries and urodynamic studies, patient 
reported outcome measurements (PROMS) are of utmost importance. A worldwide 
often used questionnaire for patients with overactive bladder symptoms is the OAB-q 
SF which is included in the value-base healthcare consortium ICHOM dataset on OAB. 
Chapter 6 reports how this questionnaire was translated and validated in the Dutch 
language. It appeared to be a valid PROM which now be used in clinical practice in the 
Netherlands. 
The protocolled use of PROMS in clinical practice is encouraged, as it may lead to 
better outcomes of personalized therapies. Prognostic factors for outcomes of both 
conservative and invasive therapies have not yet been identified. The outcomes of a 
continent catheterizable urinary channel in adults were evaluated in the study presented 
in chapter 7. This invasive therapy for patients with functional bladder problems is not 
often performed, and consequently little is known on the risk factors for complications. 
All patients who received such channel during the past 20 years in either the Erasmus 
University Medical Center or the University Medical Center Groningen were retrospec-
tively included in this study. The underlying cause for bladder disorders was neurogenic 
in 26 out of the 41 patients included in this study. The probability of a surgical revision of 
the channel due to complications like stenosis or leakage was greater than 40%. Apart 
from a higher age during surgery, no significant risk factors were identified, which is pre-
sumably related to the small patient sample. A future perspective is the development of 
a worldwide registry for patients who undergo invasive surgery for functional bladder 
disorders, including both objective and subjective outcome measurements. This will 
possibly identify risk factors for invasive surgery. As the development of such registers 
will take time, until implementation, centers need to be encourage to use validated and 
standardized outcomes.  
In chapter 8, the general discussion of this thesis, the possible applicability of dy-
namic brain imaging in functional urology, as well as the applicability of dynamic brain 
imaging in individuals is discussed. Some potential issues are that the technique is time 
consuming and prone to artefacts, and that 7T is still limitedly available and relatively 
expensive. Most of these issues are resolvable, however, when technique evolves in due 
time. The general discussion furthermore describes that clinical research in functional 
urology is challenging due to the lack of reproducible objective parameters. The main 
goal is a better prediction on outcome measures and risk factors in individual patients. 
This is a prerequisite for personalized medicine in functional urology. Relevant research 
ranging from basic science to PROMS in clinical practice must be encouraged in order to 
improve health care in the field of functional urology.  
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NEDERLANDSE SAMENVATTING
De functionele urologie houdt zich bezig met functie stoornissen van de lage urinewe-
gen, zoals de blaas en de bekkenbodem. Hoofdstuk 1 beschrijft de functie van de lage 
urinewegen met de daarbij behorende perifere en centrale neuronale innervatie. Verder 
worden de verschillende stoornissen met de daarmee gepaarde klachten samengevat. 
De diagnostiek bestaat uit objectieve en subjectieve meetinstrumenten. Objectieve 
meetinstrumenten meten feitelijke gegevens over het lichaam, zoals de plasfrequentie 
op een dag of het residu van urine in de blaas na het plassen. De subjectieve meetin-
strumenten - vaak in de vorm van een vragenlijst - meten hoeveel last iemand heeft van 
deze objectieve gegevens en hoe dit de kwaliteit van leven beïnvloedt. De functionele 
MRI (fMRI) is een relatief nieuwe dynamische beeldvormende techniek waarmee activa-
tie van hersengebieden in beeld gebracht kunnen worden. Het is dus voorstelbaar dat 
veranderingen in de functie van de lage urinewegen ook veranderingen in bepaalde 
hersengebieden teweeg brengen. Daardoor kan de fMRI als objectief diagnostisch 
meetinstrument fungeren. De behandeling van functiestoornissen van de lagere urine-
wegen bestaat primair uit conservatieve maatregelen en medicamenteuze therapieën. 
Als deze therapieën niet voldoende werken, kunnen minimaal invasieve therapieën 
worden toegepast zoals sacrale neuromodulatie of meer invasieve reconstructieve 
ingrepen zoals het aanleggen van een continent katheteriseerbaar urinestoma.
In de afgelopen twee decennia is er veel kennis over de innervatie van de urinewegen 
verworven en zijn er nieuwe behandelmethoden ontwikkeld. Desondanks zijn er nog 
grote hiaten in de kennis van de verschillende pathomechanismen en is de wetenschap 
nog niet goed in staat om de verschillende behandelvormen goed te evalueren. Dit 
proefschrift heeft als doel om nieuwe en reeds bestaande objectieve als subjectieve 
meetinstrumenten binnen de functionele urologie te evalueren en te optimaliseren.  
Deel 1 van dit proefschrift gaat in op de vraag of hoge-resolutie functionele MRI (7T 
fMRI) gebruikt zou kunnen worden in de diagnostiek binnen de functionele urologie. We 
hebben onder andere onderzoek verricht naar de hersengebieden die zijn betrokken 
bij het aansturen van de lage urinewegen, en aangetoond dat 7T fMRI een bruikbare 
techniek is om deze hersengebieden te onderzoeken. 
In hoofdstuk 2 wordt een systematisch literatuur onderzoek beschreven, wat als 
doel had een overzicht te genereren van de hersengebieden die betrokken zijn bij de 
motorische taken van de lage urinewegen.  Middels een gerichte zoekopdracht, werden 
er 19 relevante artikelen geïncludeerd, waarvan 11 artikelen de aansturing van de bek-
kenbodemspieren betrof, en 8 artikelen de aansturing van de mictie betrof. Met de data 
uit de geïncludeerde artikelen hebben we  een meta-analyse uitgevoerd in de vorm van 
een Activation Likelihood Estimation (ALE). In een ALE analyse worden de coördinaten 
van de hersengebieden die gerapporteerd worden in de geïncludeerde artikelen gezien 
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als een soort ruimtelijke kansverdeling van activatie. Alle coördinaten uit de artikelen 
worden samengevoegd en vormen een ‘gemiddeld’ activatie patroon. De ALE resulta-
ten van de bekkenbodemcontracties lieten activatie zien van de primaire motorische 
schors, de supplementaire motorische schors, de gyrus cinguli, de gyrus frontalis, de 
thalamus, de gyrus supramarginalis en het cerebellum. Verder liet de ALE analyse van 
de mictie betrokkenheid zien van het pontine mictie centrum, de periaquaductale grijs, 
de gyrus cinguli, de gyrus frontalis, de insula en de ventrale pons. Een vergelijking van 
beide analyses leverde een overlap van cluster op in slechts twee hersengebieden; de 
gyrus cinguli en de linker thalamus. Ondanks dat de bekkenbodemcontracties en de 
mictie beide motorische taken van de lage urinewegen zijn, is het aannemelijk dat ze 
door verschillende hersengebieden worden aangestuurd. Bij de interpretatie van de 
resultaten van de ALE analyse is het goed om de beperkte hoeveelheid data waarmee 
de analyse is uitgevoerd in acht te nemen. Deze schaarste aan data demonstreert de 
noodzaak voor meer onderzoek op dit gebied en daarmee ook meer kennis over de (pa-
tho)fysiologie van de lage urinewegen. Hoofdstuk 2 laat, voor het eerst een ALE analyse 
zien over de motorische aansturing van de bekkenbodem en heeft daarmee mogelijk de 
basis hersengebieden betrokken bij deze motorische taak bevestigd. 
In de hoofdstukken 3 en 4 worden de resultaten van 2 onderzoeken met 7T fMRI 
beschreven, namelijk betreffende respectievelijk motorische taken en sensorische 
taken. In eerste instantie is er een groepsanalyse gedaan van de verkregen data om 
de hersengebieden betrokken bij de bekkenbodemcontracties en de sensoriek van 
het genitaal te bestuderen. Daarnaast werd er in beide studies onderzocht of 7T fMRI 
gebruikt zou kunnen worden om het activatiepatroon van het hele brein in individuen 
te interpreteren. Als we 7T fMRI in de kliniek willen gebruiken, is het van belang dat we 
de resultaten op individueel niveau kunnen bekijken. 
Aan beide onderzoeken deden 17 vrijwilligers mee maar wegens bewegingsartefacten 
konden we uiteindelijk data van 13 personen analyseren. In hoofdstuk 3 voerden de vrij-
willigers bekkenbodemcontracties uit, en als controletaak bewogen ze de tong. Omdat 
tongbeweging net zoals bekkenbodemcontractie een motorische taak is in de midden-
lijn van het lichaam maar toch op een hele andere plek zit, konden de resultaten in het 
brein goed met elkaar worden vergeleken. In hoofdstuk 4 werden de hersengebieden 
die betrokken zijn bij het gevoel van de penis onderzocht en hierbij werd de aanraking 
van de voeten gebruikt als controle. Om aan te tonen waar op de primair sensorische 
schors de penis is gerepresenteerd, kon activatie tijdens voet aanraking goed gebruikt 
worden als referentiepunt. Beide onderzoeken lieten zien dat 7T fMRI geschikt is om de 
betrokken hersengebieden van de lage urinewegen te bestuderen in het gehele brein 
van een individu. Dit in tegenstelling tot eerder gepubliceerd onderzoek waar veran-
deringen in hersenactivatie slecht na groepsanalysen werd getoond. Een belangrijke 
bevinding in hoofdstuk 4 is de locatie van de activatie op de primaire sensorische 
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schors bij een tactiele stimulus van de penis. Het onderzoek toonde duidelijk aan dat 
de genitalia in de heup regio gerepresenteerd zijn op de primaire sensorische schors, en 
niet mediaal-craniaal van de plek op de primaire sensorische schors waar de voeten zijn 
gerepresenteerd, zoals eerder is vastgesteld. 
Het tweede deel van dit proefschrift had als doel het evalueren en verbeteren van 
objectieve en subjectieve uitkomstmaten binnen de functionele urologie. 
Als patiënten met overactieve blaas niet reageren op conservatieve of medicamen-
teuze therapieën, kan er gekozen worden om sacrale neuromodulatie toe te passen. Dit 
wordt gezien als een minimaal invasieve behandeling. Omdat op basis van de kenmerken 
van een patiënt nog niet goed voorspeld kan worden of diegene wel of geen baat heeft 
bij deze behandeling, wordt er eerst een test stimulatie uitgevoerd met een externe 
batterij als stimulator. Als blijkt dat er voldoende effect is, kan het definitieve systeem 
worden geïmplanteerd. In hoofdstuk 5 is met behulp van urodynamisch onderzoek 
onderzocht of er een acuut effect op de blaas dynamiek te zien is van de sacrale neuro-
modulatie. Een acuut effect bleek niet op te treden. Een doel om het acute effect van 
sacrale neuromodulatie te onderzoeken is om na te gaan in hoe verre een ’closed-loop 
feedback systeem’ met sacrale neuromodulatie werkzaam is. Met dit systeem wordt de 
neuromodulator automatisch geactiveerd als de druk in de blaas toeneemt. Ondanks 
het feit dat er geen acuut effect op het urodynamisch onderzoek meetbaar is sluiten 
deze resultaten een mogelijk closed loop systeem niet bij voorbaat uit. De theorie hier-
achter is dat het effect van sacrale neuromodulatie in het brein enige tijd blijft bestaan, 
nadat de sacrale neuromodulatie is gestopt. Met een ‘closed-loop feedback systeem’ zou 
deze ‘verandering’ in het brein onderhouden kunnen worden en dus het effect van de 
sacrale neuromodulatie weer kunnen oproepen. Meer onderzoek naar deze theorie is 
noodzakelijk om het systeem verder te ontwikkelen. 
Binnen de functionele urologie komen de objectieve uitkomsten vaak niet overeen 
met de subjectieve parameters. De invloed van symptomen op de kwaliteit van leven 
verschilt sterk per individu. Daarom zijn naast de objectieve uitkomsten ook de subjec-
tieve uitkomstmaten van groot belang. Een wereldwijd veel gebruikte subjectief meetin-
strument is de vragenlijst OAB-q SF voor patiënten met overactieve blaas. In hoofdstuk 
6 is beschreven hoe deze vragenlijst in het Nederlands vertaald en gevalideerd werd. 
De Nederlandstalige versie bleek een valide meetinstrument voor de perceptie van de 
patiënt met overactieve blaasklachten. 
Hoofdstuk 7 onderzoekt de uitkomsten van het aanleggen van een continent kathe-
teriseerbaar urinestoma. Deze ingreep komt oorspronkelijk vanuit de kinderurologie 
maar wordt in uitzonderlijke gevallen ook bij volwassenen met therapieresistente blaas-
functiestoornissen gebruikt. Over de lange termijn resultaten en complicaties van deze 
ingreep bij volwassenen is nog weinig bekend. In een retrospectief onderzoek werden 
de gegevens van alle patiënten die in de afgelopen 20 jaar een dergelijke ingreep heb-
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ben ondergaan geanalyseerd. In totaal werden 41 patiënten in deze studie geïncludeerd 
waarvan 26 met een neurogene oorzaak van de blaasfunctiestoornissen. De kans op 
een heroperatie wegens een stoma gerelateerd probleem was 40%. Er was geen verschil 
tussen de neurogene en niet-neurogene patiënten. Ook andere risicofactoren konden 
niet geïdentificeerd worden behalve een hoge leeftijd op het moment van de ingreep. 
In hoofdstuk 8, de algemene discussie van dit proefschrift, wordt onder andere de 
mogelijk klinische toepassing van 7T fMRI besproken. Hoofdstukken 2, 3 en 4 dragen 
bij aan de kennis over de hersengebieden betrokken bij de lage urinewegen en hoofd-
stukken 3 en 4 tonen aan dat deze techniek ook op individueel niveau gebruikt kan 
worden binnen dit vakgebied. Enkele kanttekeningen moeten hierbij worden geplaatst. 
De analyse neemt veel tijd in beslag, de techniek is duur, gevoelig voor artefacten 
en vooralsnog beperkt beschikbaar. Na verdere ontwikkeling en verbetering kan de 
techniek daadwerkelijk in de praktijk worden gebruikt. Hoofdstukken 5, 6 en 7 dragen 
bij aan de verbetering van zowel de objectieve als de subjectieve uitkomstmaten. Een 
belangrijk doel binnen de functionele urologie is om de uitkomsten van therapie en 
de kans op complicaties of bijwerkingen beter te kunnen inschatten en hierdoor een 
passende behandeling per patiënt aan te kunnen bieden. Het onderzoek naar zowel 
objectieve als subjectieve uitkomsten beschreven in dit proefschrift draagt bij aan deze 
personalisatie van zorg binnen de functionele urologie. 
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